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Abstract
Abdominal aortic aneurysm (AAA) is a dynamic vascular disease characterized
by inflammatory cell invasion and extracellular matrix (ECM) degradation. Evidence has
demonstrated a profound influence of genetic background on AAA formation. The work
presented herein discusses two studies: the first demonstrates how genetic components
can enhance the susceptibility to AAA formation and the second demonstrates how ECM
degradation enhances AAA progression by influencing inflammatory cell phenotypes. An
understanding of the pathways involved in AAA pathogenesis can help not only to
identify potential patients at risk of AAA development, a heritable disease in which the
incriminating component has yet to be discovered, but also to identify therapeutic targets
for medical therapy. By using the CaCl2 model of aneurysm formation, we were able to
induce aneurysms in two different strains of mice, C57Bl/6 and 129/SvEv. While both
strains developed aneurysms, 129/SvEv mice developed larger aneurysms, increased
inflammatory cell infiltration, and had higher MMP expression compared to C57Bl/6
mice. We believe this increased susceptibility is due to increased ProMMP-2 expression
at baseline. This increase in MMP expression may help to explain why some patients
develop aneurysms at faster rates than others or why some patients may be
predisposed to aneurysm formation while others form atherosclerotic plaque.
Furthermore, our study examines how products released from damage to the
aortic wall, particularly the breakdown of elastin and the release of elastin-derived
peptides (EDPs), influence the surrounding microenvironment. Pro-inflammatory M1
macrophages initially are recruited to sites of injury but, if their effects are prolonged, can
lead to chronic inflammation that prevents normal tissue repair. The EDPs released from
aortic wall damage create a pro-inflammatory M1 macrophage phenotype. By using
CaCl2 to induce AAA formation, we show how manipulation of this pro-inflammatory
response by direct injection of anti-inflammatory M2 macrophages can reduce aortic
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dilation. Antibody-mediated neutralization of EDPs can attenuate aortic dilation by
preventing macrophage recruitment to the damaged aortic wall, reducing MMP
upregulation, and influencing the M1/M2 phenotype ratio. By manipulating the M1/M2
ratio, we identify a potential therapeutic target in the fight to discover a medical therapy
and minimize the need for invasive mechanical intervention in AAA.
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INTRODUCTION
Abdominal aortic aneurysms (AAAs) are permanent dilations of the abdominal
aorta that, if left untreated, can lead to fatal aortic rupture. Death results from
exsanguination into the retroperitoneum or abdominal cavity and may be rapid.
Approximately 15,000 deaths due to aneurysm rupture are reported each year in the
U.S. 1 Most AAAs are diagnosed serendipitously since they are asymptomatic until the
time of rupture. Therefore, screening programs have been employed to identify the
disease in high-risk populations. 2 Risk factors include male gender, increased age (> 65
years), and a positive family history. 3-5 Additionally, smoking history is one of the major
risk factors associated with aneurysm formation. A positive smoking history predicts a
larger aneurysm size at diagnosis6 as well as a higher risk of aneurysm progression with
continued smoking. 7 Other associated risk factors for AAA formation include Caucasian
race, presence of other aneurysms, and atherosclerosis.8,9
An aortic aneurysm is defined as a 50% increase in aortic diameter. Many
screening studies use an infrarenal aortic diameter greater than 3.0 cm to define an
aneurysm. Surgical intervention is not recommended until the aorta reaches a diameter
of 5.5 cm in men and 5.0 cm in women, where the risk of rupture exceeds the risk of
repair. Currently, there are no pharmacological therapies for slowing AAA progression,
so patient management is a matter of watching and waiting until the aorta reaches a size
where repair is indicated. Animal studies using statins, β-blockers, angiotensinconverting enzyme inhibitors, angiotensin receptor blockers, and tetracyclines have
been shown to have a beneficial effect by delaying progression of aortic dilation. 10-17
Despite this, none of these drugs have proven benefit in humans. The only known
approach to slow aneurysm progression is smoking cessation.
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The pathogenesis of AAA is a highly complex process that is undoubtedly
multifactorial with, an as yet uncertain, genetic contribution. Histological features of AAA
include smooth muscle cell (SMC) apoptosis, elastin fragmentation, as well as chronic
adventitial and medial inflammatory cell infiltration. 18 Elastin fragmentation is triggered
by upregulation of various elastin-degrading enzymes such as matrix metalloproteinases
(MMPs), cysteine proteases, and serine proteases. These elastin and extracellular
matrix (ECM) fragments recruit inflammatory cells to the artery wall triggering an innate
immune response that attempts to resolve the damage. The adaptive immune response
later develops and is associated with aneurysm progression through antigen specific
antibody production. 19,20
Studies of human aortic aneurysm tissue obtained at surgery are informative but
likely reflect the end stage of the disease process. To investigate the cause of
aneurysmal disease and to determine early pathophysiological changes in AAA, animal
models are commonly used. Studies with animal models have led to advances including
recognition that chronic inflammation, increased expression of endogenous proteinases,
degradation of structural matrix proteins, and medial smooth muscle cell depletion all
play a role in the process of aneurysm development. 21,22 Genetically engineered mice
have been increasingly used to investigate the molecular mechanisms of AAA.
Important insights pertaining to inflammatory cytokines and MMPs have been obtained
from mouse studies involving targeted disruptions of genes such as interferon-γ (IFN-γ),
tumor necrosis factor-α (TNF-α), MMP-2, and -9.	
  23-‐26
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CHAPTER 1
Inflammatory cell phenotypes in AAAs
The following is a modified version of an article published in Arteriosclerosis,
Thrombosis, and Vascular Biology 2015 Aug;35(8):1746-55. The work was coauthored
by Melissa K Ruhlman, B. Timothy Baxter, and myself.
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Brief review: Innate and adaptive immune system
The immune system is a complex arrangement of many cell types and molecules
interacting to maintain homeostasis. The first basic distinction is the difference between
innate and adaptive immunity. The innate immune system comprises all of the immune
responses present from birth whereas the adaptive immune system consists of those
responses generated after exposure to specific new antigens. The innate immune
system is considered the first line of defense against invading microorganisms and is
made up of the cells and molecules that act as first responders in the face of an insult. 27
It has been conserved throughout evolution with similar molecular components found in
simple eukaryotes and more complex organisms including humans.

27

The adaptive

immune system developed later in evolution and can acquire what is considered
immunologic “memory.” After exposure to a novel pathogen, the adaptive immune
system tailors its response while maintaining self-tolerance (except in autoimmune
diseases). These responses are typically controlled with an acute phase and subsequent
resolution. In aneurysmal disease, it is believed that there is ongoing, poorly regulated
inflammation resulting in progressive tissue damage and aneurysm expansion.

Inflammatory cells in AAAs
The transmural inflammation seen in AAA involves a variety of inflammatory cell
types, where macrophages and lymphocytes are the most prominent with mast cells and
neutrophils migrating to a lesser extent. 28-31 Ocana et al. demonstrated that both T- and
B-lymphocytes are present in AAA tissue, where the majority of the infiltrating
lymphocytes are cluster of differentiation four positive (CD4+) T cells. 32 No natural killer
(NK) cells were detected in tissue from AAA patients; 32 however, peripheral blood levels
of NK cells were significantly higher in AAA patients compared to controls.

33

The

presence of B- and T- lymphocytes suggests antibody-mediated humoral immunity and
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potentially an autoimmune process driving AAA formation or progression. Previous
animal studies have reported that without the presence of CD4+ T cells, AAA formation
does not occur. 34 Furthermore, experimental AAA formation is mediated by interleukin
(IL)-17, a cytokine notably produced by pro-inflammatory CD4+ T cells. 35 These proinflammatory CD4+ T cells exacerbate AAA disease progression and play a role in
creating chronic inflammation in the damaged aortic wall (Figure 1.1).
Macrophages have also been shown to play a key role in AAA progression.
Macrophages are key components of the inflammatory process. Tumor necrosis factor
(TNF)-α, IL-6, IL-1β, and interferon (IFN)-γ are pro-inflammatory macrophage-associated
cytokines studied as biomarkers of AAA progression. 36,37 Although all of these cytokine
levels are elevated in patients with AAA compared to controls, only IFN-γ levels had a
positive correlation with AAA progression. Macrophages are recruited to injury sites by
ECM degradation products and numerous chemokines. These chemokines, monocyte
chemotactic protein (MCP)-1, IL-8, and TNF-α, are colocalized to infiltrating
macrophages. 38-40 Macrophages recruited to AAA tissue begin a positive feedback loop
creating chronic inflammation, but they may not always be harmful in AAA development
(Figure 1.1). Macrophages, like T cells, display plasticity and have the ability to polarize
to various phenotypes, such as the classically activated (M1) phenotype or the
alternatively activated (M2) phenotype. M1 macrophages are typically characterized by
pro-inflammatory cytokine production and initiate tissue degradation, whereas M2
macrophages are implicated in inflammation resolution and tissue repair. An M1/M2
imbalance may be occurring in AAA, where strategies targeting a stronger M2 response
may prove a potential therapeutic target to reduce chronic inflammation in AAAs.
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Figure 1. Schematic representation of inflammatory cell infiltration in AAAs. A
normal aorta is represented on the left with intact endothelial and elastin layers. The wall
of the aneurysmal aorta consists of robust inflammatory cell infiltration. T cells and
macrophages primarily migrate to the adventitia, with lesser infiltration into the media.
Pro-inflammatory Th1 and Th17 cells predominate whereas infiltration of antiinflammatory Tregs and Th2 cells occurs to a lesser extent. A macrophage phenotype
imbalance exists with more pro-inflammatory M1 macrophages (M1 MΦ) than antiinflammatory M2 macrophages (M2 MΦ) in the aneurysmal aortic wall. During the initial
aortic growth phase, thickening of the adventitial layer occurs, resulting in increased total
wall thickness. Aneurysm formation and inflammation results in breakdown of medial
elastin and smooth muscle cell (SMC) apoptosis, causing a thinning of the medial layer.
Loss of the endothelial cell (EC) layer is replaced by an intraluminal thrombus (ILT).
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Figure 1. Schematic representation of inflammatory cell infiltration in AAAs. A normal aorta is
represented on the left with intact endothelial and elastin layers. The wall of the aneurysmal aorta
consists of robust inflammatory cell infiltration. T cells and macrophages primarily migrate to the
adventitia, with lesser infiltration into the media. Pro-inflammatory Th1 and Th17 cells predominate
whereas infiltration of anti-inflammatory Tregs and Th2 cells occurs to a lesser extent. A macrophage
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Inflammatory cells in atherosclerosis
Atherosclerosis is an inflammatory disease beginning in the intima of large and
medium sized arteries caused by accumulations of low-density lipoproteins (LDL). A
wide range of inflammatory cell types has been found in advanced atherosclerotic
lesions including but not limited to macrophages/monocytes, lymphocytes, and dendritic
cells. 41 Infiltration of these inflammatory cells occurs primarily in the neointima, aiding in
the inward rather than outward remodeling in atherosclerosis. Glagov et al. were the first
to describe compensatory outward remodeling that partially compensated for intimal
expansion. 42 A recent study proposed that IL-1 is an important factor that enhances
outward remodeling, protecting the artery from stenosis. 43 Inhibition of the IL-1 pathway
actually enhanced macrophage infiltration and caused further narrowing of the arterial
lumen. MMPs assist in the outward remodeling process and are implicated as a cause of
AAA formation, but in atherosclerosis, MMPs are predominantly expressed in the
atherosclerotic plaque, leading to plaque instability.

44,45

In contrast, Figure 1

demonstrates that the inflammatory lesions in AAA tend to occur in the outer layers of
the media and adventitia, where they may be expected to have a greater impact on
outward remodeling. The presence of inflammatory cells and their associated cytokines
and proteases may protect from arterial narrowing by promoting outward remodeling.
Taken to the extreme, this inflammatory response may promote overcompensation in the
outward remodeling process by causing aneurysm formation. 46

Inflammatory cells in diabetic atherosclerosis
Diabetes is an important risk factor for the development of atherosclerotic
lesions. Irreversible formation of advanced glycation end products (AGEs) is implicated
as a cause of accelerated atherosclerosis. 47 The interaction of AGEs with mononuclear
phagocytes induces a pro-inflammatory macrophage phenotype, resulting in production
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of various pro-inflammatory cytokines such as TNF-α and IL-1β.

48-50

Interestingly,

diabetes is negatively associated with AAAs. 6,51 This negative correlation may be related
to the formation of AGEs and alterations to ECM proteins. Golledge et al. found that
aortic tissue from patients with diabetes have decreased activities of MMP-2 and MMP9.

52

Modification of collagen lattices by glycation or treatment with glutaraldehyde

reduced MMP activity. These findings suggest that modification of ECM proteins reduces
protease activity, potentially preventing aortic wall degeneration and aneurysm
formation.

CD4+ and CD8+ T cells
A review of the cell types involved is critical to understanding the role of
inflammation in AAA development and progression. T cells are a heterogeneous group
of lymphocytes with a diverse classification system and multitude of physiologic actions.
They are initially classified based on surface expression of CD4 or CD8 molecules. CD4+
cells recognize antigens presented by major histocompatibility complex (MHC) Class II,
while CD8+ cells recognize antigens presented by MHC Class I, important in cellmediated toxicity. 53 Most modulatory T cells express CD4 while most cytotoxic T cells
express CD8. The CD4+ T cell has been found to be the predominant cell type in human
aneurysm tissue. Through its profile of secreted cytokines, the CD4+ T cell indirectly
controls matrix metabolism by recruitment of macrophages and regulation of ECM and
protease synthesis.

T cell phenotypes: Th1, Th2, Th17, and Treg
CD4+ T cells can be further subdivided into the T helper (Th) or T effector (Teff)
subsets: Th1, Th2, and Th17 and the regulatory subset: T regulatory (Treg) cells. Each
subset is classified by the cytokine profile required for stimulation, their secreted
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products, and their physiologic actions. In human disease, there is rarely polarization to
one specific cell phenotype but an imbalance between pro-inflammatory and antiinflammatory CD4+ cells may enhance aneurysmal disease progression.

Th1
The Th1 cell has been linked to many chronic auto-inflammatory disorders
including: 54,55 rheumatoid arthritis, 56 emphysema, 57 and systemic lupus erythematosis.
58

Th1 cells are characteristically activated by IL-12, triggering the signal transducer and

activator of transcription 4 (STAT4) and T-bet pathway to produce IFN-γ, TNF-α, and
TNF-β (Table 1.1).

54,55,59-63

This leads to activation of macrophages and an internal

autoregulatory loop to potentiate Th1 development and inhibit alternate T cell
differentiation. Through this cycle, IFN-γ activates macrophages and enhances
inflammatory cell recruitment through augmenting cytokine, chemokine, and adhesion
molecule expression. 60,61 Macrophages then produce additional IL-12, which promotes
further Th1 activation. 54,60 This potentiates a cycle of matrix destruction and enhanced
aneurysm formation. Interestingly, the best data available is conflicting regarding the
expression of IL-12 and its downstream transcription factor STAT4. IL-12 protein levels
are decreased in AAA tissue compared to aortic occlusive disease tissue. 60 Conversely,
STAT4 levels are upregulated in AAA compared to non-aneurysmal control.

64

This

apparent inconsistency may be due to different controls used for each study. The
decrease in IL-12 from AAA patients was in comparison to patients that have severe
atherosclerosis, whereas the STAT4 increase from AAA patients was in comparison to
organ donors who likely had minimal disease.
Galle et al. found human aneurysmal tissue expressed high levels of IFN-γ but
not IL-4, a typical Th2 marker.

29

They also identified overexpression of T-bet, the

intracellular signaling pathway for Th1 polarization, without significant Th2 signaling.

	
  

11

Table 1.1
Table 1.1. Th cell differentiation, function, and role in disease.
Th1
Th2
Th17
Stimulating Factors
IL-12
IL-4
IL-23, IL-1, IL-6

Treg
IL-2, TGF-β

Pathway

STAT4, T-bet

STAT6, GATA-3

RORγt, STAT3

STAT5, Foxp3

Secreted Products

IFN-γ

IL-4, IL-5, IL-10,
IL-13

IL-17A & F

IL-10 & TGF-β

Role in Disease

Macrophage
activation,
↑Inflammatory
cell recruitment

Limit macrophage
cytotoxicity,
↓MMPs &
cytokines (IL-4/10),
↑MMPs (IL-13)

↑macrophage
recruitment

↓Teff proliferation,
↓TNF-α & IFN-γ
secretion from Teff
and macrophages,
remove
autoreactive T cells
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This suggests robust presence of the Th1 cell with minimal Th2 involvement in end
stage human disease. Juvonen et al. found elevated serum levels of IFN-γ in humans
with AAA, which correlated with an increased aneurysm growth rate.

36

We have

previously demonstrated that mice deficient in CD4+ T cells had attenuated MMP
expression and no aneurysm formation in a murine model of AAA, where replacing IFN-γ
alone reconstituted aneurysm formation. 34 This contrasts with work done in the ApoE-/model of AAA, where Rag1 deficiency had no effect on reducing aneurysm size. 65 This
was also true for IFN-γ and its downstream transcription factor STAT1 in the ApoE-/model. 66,67 These data highlight differences in the models. The CaCl2 model relies on an
inflammatory response for aneurysm formation whereas the ApoE-/- model depends to a
much greater extent on a combination of hemodynamics and hypercholesterolemia.
Taken together, the animal models have failed to elucidate a clear role of lymphocytes
and IFN-γ in AAA (Table 1.2).

Th2
The Th2 cell, along with its cytokine profile, is largely considered antiinflammatory.

Interestingly, the Th2 cell can also be associated with inflammatory

processes including IgE-mediated antibody responses, allergy, and asthma. 54,61,63 IL-4
drives the differentiation of CD4+ T cells into the Th2 phenotype. Through the STAT6
and GATA-3 pathway, the Th2 cell secretes IL-4, IL-5, IL-10, and IL-13 (Table 1). 54,55,6063

IL-4 and IL-10 limit the cytotoxic potential of macrophages and decrease expression of

pro-inflammatory mediators and MMPs. IL-13 enhances development of antiinflammatory M2 macrophages but also increases MMP expression. 60,61
The Th2 cell profile has been implicated as a culprit in aneurysmal disease in
both human and murine studies.

68

Schonbeck et al. found increased levels of Th2

associated cytokines and low expression of Th1 related cytokines, particularly IFN-γ, in
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Table 1.2.
Table 1.2. Th cell differentiation in human and experimental AAA.
Th1
Th2
Th17
23, 30
54,56
29,65
Human AAA
Increased
Increased
Increased
23
Decreased
ApoE AngII model

-/-

Increased

60

Increased

62

CaCl2 model

Increased

28

Undefined

Undefined

Elastase-perfusion
model

Undefined

Undefined

Increased

Increased

65,66

29,65

Treg
69
Decreased
Decreased
Undefined
Undefined

65,70
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human tissue. 60 They suggested that IL-4 overexpression prevents Th1 differentiation
and that IL-4 and IL-5 induced chemoattraction of neutrophils contributes to excessive
elastolytic activity. Shimizu et al. showed that in allografted mice aortas, AAA
development was more severe in IFN-γ deficient mice while mice deficient in IL-4 were
protected from AAA.

61

Contradictory to the murine data, IL-4 has been shown to

stimulate production of ECM proteins in human fibroblasts and suppress MMP
expression (MMP-1 and MMP-9) in human alveolar macrophages.

69,70

Chan et al.

suggested an alternate source for the Th2 associated cytokines; another member of the
T cell family, the natural killer (NK) T cell. 62 NK and NKT cells produce both IL-4 and
IFN-γ and have a profile that is neither Th1 nor Th2; referred to as Th0. Unlike most
immune cells whose function appears to decline with age, the NK and NKT cells
increase in number and produce greater IL-4 with advancing age. The important role of
the Th2 cell may be specific to the murine transplant model, as other murine models
show Th1 predominance. The conflicting data between the Th1 and Th2 profiles may
relate to technical differences in how measurements were made, differences in animal
models, and the late disease state at which human aneurysm samples are obtained
(Table 1.2).

Th17
A more recently identified distinct subclass of T helper cell, the Th17 cell, has
generated interest with regard to its potential role in AAA. This cell type is unique from
Th1 and Th2 cells based on both its cytokine profile and differentiation pathway. 59 The
Th17 cell is stimulated by IL-23, IL-1, and IL-6, which primarily induce retinoic acid
receptor–related orphan receptor γt (RORγt) and STAT3, leading to secretion of IL-17
(Table 1.1).

55,59,63,71

IL-17 has 6 known isoforms, A through F, of which Th17 cells

secrete IL-17A and F. IL-17A, its primary cytokine, mediates many immune and
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inflammatory diseases and is critical for vascular superoxide production. 72 The Th17 cell
promotes macrophage recruitment to the vascular wall while deficiency of IL-17 appears
to reduce aortic macrophages in murine models.71,72
Madhur et al. found aneurysm formation in the ApoE-/- murine model to be
unchanged when comparing control mice to IL-17 knockout mice. 72 This suggested that
IL-17 did not have a critical role in this murine model. In contrast, Sharma et al. showed
that IL-23 and Il-17 expression was increased in human AAA.

35

Using an elastase-

perfusion murine model, deletion of IL-17 or IL-23 attenuated aneurysm development
and decreased pro-inflammatory cytokine production. Furthermore, mesenchymal stem
cell treatment, at the time of aneurysm induction, decreased IL-17 production and
reduced aortic dilation. Recently, Wei et al. showed that the T helper and IL-17
inflammatory response was diminished by administration of digoxin in a dose dependent
manner. 71 This was associated with a decrease in AAA incidence and increased mouse
survival in the ApoE-/- and elastase-perfusion murine models. Digoxin was found to
antagonize RORyt, inhibit Th17, and augment Treg cells. This growing body of evidence
suggests an important role of the Th17 cell in promoting inflammation and enhancing
aneurysmal disease.

Treg
Treg cells are a unique subclass of CD4+ T cells that function to counteract the
pro-inflammatory effects of the T effector subclasses and are important in immune
tolerance. IL-2 and transforming growth factor (TGF)-β stimulate Treg cells, which
produce IL-10 and TGF-β through the STAT5 and forkhead box P3 (Foxp3) pathway
(Table 1.1).

55,63

The Treg assumes the critical function of curtailing the inflammatory

process, limiting collateral damage, and allowing matrix repair to begin. Known functions
of Treg cells include blocking further proliferation of Teff cells,

63,73

inhibiting the

	
  

16

inflammatory cascade by blocking TNF-α and IFN-γ secretion from effector cells and
invading macrophages,48 and removal of autoreactive T cell clones generated in
response to matrix degradation products.74 Because one of the most important functions
of the Treg cells is to limit the proliferation of Teff cells, a relative increase in Teff cells
indicates a loss of control of the inflammatory response. Yin et al. showed a reduction in
the proportion of Treg cells in AAA patients. 75 Increasing the Treg population, by injection
of splenic Treg cells from a donor mouse, protected ApoE-/- mice from aneurysm
formation. 76 An imbalance in the proportion of the Treg cell population or dysfunction of
the Treg cell has been implicated in other chronic inflammatory processes, including
COPD, 57,77 inflammatory bowel disease, 78,79 lupus, 58,80,81 scleroderma, 82,83 and organ
rejection. 84,85 Importantly, matrix destruction, which leads to end stage disease in each
of these processes, appears to represent collateral damage from an uncontrolled
inflammatory response. Normally functioning Treg cells have the potential to limit matrix
damage by inhibiting T cell proliferation, blocking TNF-α and IFN-γ secretion, and
removing autoreactive T cells.
In summary, the majority of CD4+ cells are effector T cells whose specific role is
largely confined to regulation of the acute inflammatory response as part of their central
purpose in the adaptive immune system. With an acute insult, these cells are pivotal to
the normal host defense. As part of this initial and aggressive response, the Teff cells
secrete and induce the secretion of proteases allowing the inflammatory cells to migrate
into tissues to establish contact with the injurious agent. In normal conditions, the Treg
allows for resolution of this response once the threat has been curtailed. In chronic
inflammatory processes such as AAA, this pro-inflammatory and proteolytic milieu is not
adequately opposed by anti-inflammatory mechanisms. The result is significant and
progressive destruction of the ECM.
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Macrophage phenotypes: M1 and M2
Macrophages play crucial roles in the innate and adaptive immune responses
and have been studied in various diseases since their discovery in the late 19th century
by Élie Metchnikoff. Like other immune cells, macrophages respond to various stimuli in
their microenvironmental milieu. These highly plastic cells play dual roles in initiation and
resolution of inflammation. The macrophage population consists of two major
phenotypes, M1 and M2. M1 macrophages respond to stimuli that enhance and sustain
ongoing inflammation via production of proteolytic enzymes and pro-inflammatory
mediators. Initial arterial injury leads to recruitment of M1 macrophages. Normally, these
infiltrating macrophages would later convert to M2 macrophages, promoting tissue repair
and wound healing. This M1/M2 balance is vital to proper wound repair and resolution of
the inflammatory response.

If the M1 phenotype continually predominates, chronic

inflammation occurs. Conversely, if the M2 phenotype predominates, ongoing infection
or poor wound healing may result. In certain cancers this M2 imbalance has been shown
to be detrimental, actually leading to tumor growth. 86,87 Histologically, AAA tissue shows
marked inflammatory cell infiltrates. Evidence suggests a chronic inflammatory milieu
where the M1 phenotype is not adequately balanced by the M2 phenotype, consistent
with progressive aneurysm expansion.

M1
M1 macrophages respond to environmental stimuli and sustain ongoing
inflammation via production of proteolytic enzymes and pro-inflammatory mediators. The
classical M1 macrophage phenotype can be activated in vitro by pro-inflammatory
cytokines including IFN-γ and TNF-α. IFN-γ primes the macrophages for activation but is
inadequate alone to produce the M1 phenotype. 88 A secondary signal, such as TNF-α or
lipopolysaccharide (LPS), is required for the activation of toll-like receptor 4 (TLR4)
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resulting in M1 macrophage polarization.

89

This phenotypic polarization triggers

production of various M1 markers such as inducible nitric oxide synthase (iNOS), TNF-α,
IL-1β, and other pro-inflammatory mediators (Table 1.3). Characteristic cell surface
markers, including those associated with antigen presentation such as CD80 and CD86,
can further identify these cells as M1 macrophages. The M1 macrophage products may
produce a positive feedback loop resulting in chronic inflammation and significant tissue
damage.
In AAAs, examination of these M1 markers in human tissues and in experimental
animal models has yielded noteworthy results. Many studies have focused on the
discovery of novel biomarkers in AAA patient serum. Through these studies, researchers
have identified some potential targets, which are associated with the M1 phenotype.
Although human studies of macrophages in AAA have been limited to examination of
end stage disease tissue or circulating monocytes, key findings have emerged.
Circulating monocytes from AAA patients displayed enhanced adhesive activity to the
endothelial cell wall and increased MMP-9 production.

90

Although these monocytes

were not studied specifically for M1 or M2 markers, their presence suggests a systemic
inflammatory response, which would be expected due to the presence of high levels of
MMP-9 resulting in tissue breakdown. Hance et al. demonstrated that monocyte
chemotaxis to AAA tissue can be directly linked to breakdown of the ECM, specifically
via a six-peptide sequence (VGVAPG) found mainly in elastin. 91 Experimental animal
studies have shown that blocking the presence of the VGVAPG sequence with a
monoclonal antibody reduces monocyte/macrophage recruitment limiting further ECM
breakdown.

92-94

These ECM breakdown products act as pro-inflammatory mediators,

further recruiting monocytes and promoting their differentiation into M1 macrophages.
Once initiated, the resolution of this inflammatory response is unlikely.
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Table 1.3
Table 1.3. Macrophage differentiation, function, and role in disease
M1
M2
Stimulating Factors
TNF-α, IFN-γ, LPS
IL-4, IL-13, IL-10
Pathway

STAT1, AP-1, NF-κB

STAT6, PPAR-γ, CREB

Secreted Products

TNF-α, IL-6, IL-1β, iNOS,
MCP-1

Arg1, Ym1, FIZZ1 (mouse
only)

CD markers

CD80, CD86, CD16, CD14

CD206, CD163

Role in Disease

Pro-inflammatory, cytotoxicity,
microbicidal activity, tumor
suppression

Anti-inflammatory, matrix
remodeling, tissue repair,
tumor suppression

AP – activator protein, NF-κB – nuclear factor-κB, PPAR – peroxisome proliferatoractivated receptor, CREB – cAMP response element-binding protein, Arg – arginase,
Ym1 – Chi3l3 (Chitinase 3-like-3), FIZZ – found in inflammatory zone
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Various cell surface markers are associated with M1 macrophage polarization.
CD14 acts as a co-receptor with TLR4, which is required for M1 polarization through the
IFN-γ and LPS activation pathway. 95 Recent studies showed that patients with AAAs
have increased levels of CD14+CD16+ monocytes compared to control patients,
suggesting these monocytes may be associated with the chronic inflammatory process
of AAA.

96

CD16, a low affinity Fc receptor for IgG antibodies involved in antibody-

dependent cytotoxicity, is also associated with an M1 macrophage polarization.

97

Experimental aneurysm models indicated that CD14 deletion reduced inflammatory cell
infiltration therefore reducing AAA incidence.

98

With the increase in CD markers

associated with increased pro-inflammatory processes, it is clear that the M1 phenotype
plays a major role in AAAs, at least in the latter stages of disease when tissue samples
are obtained.
Examination of pro-inflammatory cytokines in AAAs has been more extensive
and has led to many treatment strategies focused on their antagonism. M1 associated
pro-inflammatory cytokines TNF-α, IL-6, IL-1β, and IFN-γ were all increased in human
aneurysmal tissue and serum (Table 1.4). 36,37 IFN-γ is one stimulus that activates M1
macrophage polarization, and deletion of IFN-γ in experimental mouse models inhibited
aneurysm formation and macrophage infiltration.

34

Another M1 associated cytokine,

TNF-α, stimulates M1 macrophage polarization resulting in further TNF-α production.
Genetic deletion of TNF-α or antibody-mediated sequestration with Infliximab reduced
macrophage infiltration and aneurysm formation in a murine model. 99 Similar deletion
studies focused on M1 associated cytokines IL-6 and IL-1β have yielded comparable
results. 100,101 Without these M1 polarizing cytokines, aneurysm formation is dramatically
reduced and macrophage infiltration is minimized. These data are now being further
investigated in a translational study using Canakinumab, an IL-1β neutralizing antibody,
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Table 1.4
Table 1.4. Macrophage differentiation in human and experimental AAA.
M1
M2
30,31,90
101,102
Human AAA
Increased
Increased
ApoE AngII model

-/-

Increased

92

Increased

CaCl2 model

Increased

28,93,94,95

Undefined

Increased

92

Undefined

Elastase-perfusion model

103
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in patients with small AAAs with a goal of inhibiting aneurysm expansion
(NCT02007252). 102

M2
In contrast to classically activated M1 macrophages, alternatively activated M2
macrophages are associated with wound repair and inflammation resolution. M2
activation is achieved by IL-4 or IL-13, both antagonizing the actions of IFN-γ. IL-4 and
IL-13, associated with Th2 cells, bind to the IL-4 receptor and signal M2 polarization
through STAT6.

103,104

Polarization of macrophages to an anti-inflammatory M2

phenotype results in production of anti-inflammatory cytokines including IL-10 and TGFβ. The M2 macrophage is identified by markers such as mannose receptor (CD206),
arginase I, and CD163 (Table 1.3). These anti-inflammatory markers have been
identified in tumors, where tumor-associated M2 macrophages suppress the natural
immune response to cancer cells.

105

However, in diseases associated with chronic

inflammation such as AAA, enhancement of the M2 response could potentially limit the
ongoing inflammatory response.
A few recent studies have examined one of the most common M2-linked
markers, CD206. CD206 regulates the levels of glycoproteins released after
inflammatory responses, aiding in wound resolution. 106 Examination of CD206 in human
AAA tissue has revealed contrasting results. Boytard et al. demonstrated that CD206+
macrophages are present in the intraluminal thrombus (ILT) but absent in the heavily
damaged aortic adventitia. 107 Conversely, Dutertre et al. found CD206+ macrophages to
be present in the damaged aorta, potentially signaling wound resolution.

108

An

experimental aneurysm model using ApoE-/- mice revealed increased CD206 staining in
the more severely affected tissue. 109 These contradictory data indicate the further need
for M2 phenotype clarification and examination of additional M2 markers. Despite the
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conflicting results, targeting the M1/M2 imbalance may offer an interesting therapeutic
aim in aneurysmal disease.

Neutrophils and mast cells
Neutrophils are quickly recruited to sites of injury and are characteristic of acute
inflammation. 110 These cells are most commonly found in the ILT in AAAs. 111,112 While
ILT are frequently found in human AAAs, animal models fail to recapitulate formation of
an ILT.

113

However, examination of neutrophils in AAA has elucidated important

findings. In an elastase-perfused model of aneurysm formation, depletion of
polymophonuclear neutrophils reduced aortic dilation in a MMP-independent manner. 114
Human AAA studies revealed a negative correlation of neutrophil catalase activity and
aortic size. 115 These studies indicate a role for neutrophils in aneurysm formation that
may depend on regulation of reactive oxygen species.
Mast cells are inflammatory cells associated with immediate hypersensitivity and
chronic allergic reactions.

116

These cells have been found in human AAA tissue,

primarily residing in the media and adventitia.

117,118

Genetic deletion of mast cells

protects against aneurysm formation in both the elastase-perfusion and CaCl2 murine
models of aneurysm formation.

119

MMP-2 and -9, as well as other ECM degrading

enzymes, can be activated by mast cell secreted chymase, promoting aneurysm
formation. 120,121 Although much of the focus on aneurysm formation has been on T cells
and macrophages because they are the predominant inflammatory cells, interactions
between these and other inflammatory cells also play a role in aneurysm formation.

Discussion
AAA is a complex disease where an improper balance of T cell or macrophage
phenotypes may worsen the disease process. This imbalance that occurs with the
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numerous cell types involved in AAAs enhances the chronic inflammatory aspect of the
disease. CD4+ T cells display many different phenotypes, most of which have been
found in AAA tissue. Studies targeting the switch of T cells from a pro-inflammatory
phenotype to an anti-inflammatory phenotype, such as upregulation of Treg cells, create
exciting new strategies for targeting AAA progression. Macrophage phenotype
polarization is a promising new field that may prove beneficial in identifying key
regulators of chronic inflammation in AAA. Whether macrophages in AAA tissue exhibit a
stronger M1 or M2 phenotype and altering the M1/M2 balance are being explored.
Understanding and addressing the imbalances in the immune system associated with
AAA offer new and exciting translational strategies.
It is difficult to determine the cause of AAA in humans because of the chronicity
of the disease and the problem of obtaining specimens at different stages of the disease
Therefore, investigators have attempted to make use of animal models with similarities
to the human disease. Validations of these animal models must be performed by
correlating these studies with human tissueobtained from patients with end stage
disease. Correlating data obtained from murine models to human AAA tissue has yet to
yield useful therapeutic inflammation thus far. Therefore, development of humanized
animal models may help to alleviate some of the differences seen in the human and
mouse disease process. Opportunities to obtain human AAA tissue are becoming more
limited due to the transition from open to endovascular aneurysm repair. Clinical trials
must develop protocols to examine as many parameters of the disease as possible,
including serially obtaining precise imaging and circulating biomarkers. By correlating
biomarkers with changes in aneurysm shape and size, it may be possible to develop a
greater understanding of which bioactive molecules and cell types promote aneurysm
growth.
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CHAPTER 2

Genetic differences in MMP levels influence AAA susceptibility
The following is a modified version of an article published in Atherosclerosis 2015 Dec;
243(2):621-9. This work was coauthored by Melissa K. Suh, Shijia Zhao, Trevor
Meisinger, Linxia Gu, Vicki J. Swier, Devendra K. Agrawal, Timothy C. Greiner, Jeffrey
S. Carson, B. Timothy Baxter, Wanfen Xiong, and myself.
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Introduction
Abundant evidence has demonstrated the profound influence of genetic
background on cardiovascular phenotypes.	
  122-‐125 Although a single gene mutation has
not been found in association with most AAAs, a positive family history of AAA in a first
degree relative is known to increase the risk of aortic aneurysm by up to a factor of ten.	
  
126

Attempts to define the genetic component(s) underlying AAA have used a variety of

strategies, including both linkage analysis and candidate gene approaches;	
  

127

nonetheless, a consensus on the patterns of inheritance or specific linkages associated
with AAA has yet to emerge.
A variety of different mouse strains have been used to assess aortic aneurysms.	
  
109,128-‐131

The most widely used parent strains for the production of mutants in aneurysm

research are C57Bl/6 and 129/SvEv mice.

25,26,132

In contrast to AAA, thoracic aortic

aneurysms are associated with a number of known genetic mutations. Marfan syndrome
(MFS) is caused by fibrillin-1 gene mutations that are responsible for thoracic aneurysm
development. 133 Studies of animal models of MFS have shown that genetic backgroundrelated variations, C57Bl/6 or 129/SvEv, affect aneurysm formation, rupture, and lifespan
of mice.

132,134

The 129/SvEv genetic background is associated with more rapid

aneurysm progression in MFS mice when compared to the C57Bl/6 background.	
  132 As
in AAA, higher MMP-2 expression in the aorta of Marfan syndrome mice plays an
important role in aneurysm formation. 133 Therefore, the variance of thoracic aneurysm
susceptibility in MFS could also be informative regarding the underlying genetic
susceptibility to AAA. In reviewing our previous studies, we noted that 129/SvEv mice
also developed larger AAAs compared to C57Bl/6 mice in response to CaCl2-aneurysm
induction.	
  25 Based on these observations, we hypothesized that the difference seen in
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aneurysm susceptibility between the two genetic backgrounds is related to intrinsic
differences in smooth muscle cell MMP-2 or macrophage MMP-9 expression.
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Methods
Animal aneurysm model. All procedures and animal studies were approved by the
University of Nebraska Medical Center IACUC. The experimental groups consisted of 24
eight weeks-old male C57Bl/6 mice (The Jackson Laboratory, Bar Harbor, Maine) and
20 eight weeks-old male 129/SvEv mice (Taconic, Germantown, New York). Mice were
anesthetized and underwent laparotomy. The abdominal aorta between the renal
arteries and bifurcation of the iliac arteries was isolated from the surrounding
retroperitoneal structures. The diameter of the aorta was measured using a Leica
Application System (Leica Microsystems Inc, Buffalo Grove, IL).

After baseline

measurements, 0.25 M CaCl2 was applied to the aorta with care taken to avoid
surrounding tissue. After 15 minutes the aorta was rinsed with 0.9 % sterile saline, the
laparotomy incision was closed, and mice were returned to their cages after recovery.
Six weeks later the mice underwent repeat laparotomy, dissection, and measurement of
the aorta. Aortic diameter was measured at the point of maximal dilatation. The aorta
tissue was collected for zymographic and Western blot analyses. For histological
studies, the aorta was perfusion-fixed with 10% neutral buffered formalin. NaCl (0.9%)
was substituted for CaCl2 in sham controls.

Isolation and infusion of myelogeous cells. To evaluate the role of the myelogenous
cells on aneurysm susceptibility, 6 week-old C57Bl/6 or 129/SvEv mice were irradiated
(1200 rads) and transplanted with bone marrow from 129/SvEv (designated as
C57bkg/SvEvbm mice) or C57Bl/6 mice (SvEvbkg/C57bm mice), respectively. As controls,
we also transplanted bone marrow from C57Bl/6 or 129/SvEv mice into the irradiated,
same back ground mice, C57Bl/6 (designated as C57bkg/C57bm) or 129/SvEv (
SvEvbkg/SvEvbm), respectively. We have previously demonstrated that this radiation
protocol results in bone marrow ablation and is fatal without rescue by bone marrow
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transplantation.	
   135 Bone marrow cell suspensions were prepared from the femurs of
C57Bl/6 or 129/SvEv mice, and 5 × 106 cells were infused via the lateral tail veins.
Aneurysm induction followed 1 week after bone marrow transplantation.

Western blot analysis and gelatin zymography. Aortic proteins were extracted as
previously described.

133

The protein concentration of aortic tissues was standardized

with a Bio-Rad protein assay. Equal amounts (10 µg) of aortic extracts were loaded
under reducing conditions onto a 10% SDS-polyacrylamide gel and transferred to a
polyvinylidene difluoride (PVDF) membrane (Amersham Biosciences, Piscataway, NJ).
The membranes were then incubated with rabbit anti-tropoelastin antibody (Elastin
Products Company, Owensville, MO) or rabbit anti-collagen1a antibody (Cell Signaling,
Danvers, MA). The bound primary antibody was detected with HRP-linked anti-rabbit IgG
(Cell Signaling). Immunoreactive bands were visualized by autoradiography using ECL
(Amersham Biosciences). Gelatin zymography for aortic tissue extracts was performed
as described previously by Longo et al., with 0.8% gelatin in a 10% SDS-polyacrylamide
gel.7 (Longo 2002) The molecular sizes were determined using protein standards from
Fermentas (Glen Burnie, MD). The intensity of each band was quantified by
densitometry (Amersham Biosciences).

Microscopy. 1)Verhoeff-Van Gieson (VVG) connective tissue staining: After perfusionfixation with 10% neutral-buffered formalin, mouse abdominal aortic tissues were
embedded in paraffin and cut into 4 µm sections. The slides were stained with Verhoeff’s
solution, ferric chloride, sodium thiosulfate, and Van Gieson’s solution (Poly Scientific,
Bay Shore, NY). Each staining cycle alternated between fixing and washing procedures.
The slides were examined and photographed using light microscopy (Nikon). 2)
Quantification of Elastin Disruption: slides of both CaCl2 treated C57Bl/6 and 129/SvEv
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mice were examined under low power magnification. A semi-quantitative analysis was
used to estimate the percentage of the total circumference that demonstrated elastin
disruption. The analysis was performed by an observer blinded to mouse background. 3)
Immunohistochemistry: Tissue sections on the slides were deparaffinized in xylene,
rehydrated in ethanol, and rinsed in double-distilled water. The sections were incubated
with a monoclonal rat anti-mouse Mac3 antibody (PharMingen, San Diego, CA) diluted
1:500 for 30 minutes at 37oC. The sections were then briefly washed in citrate solution
and subsequently incubated with the secondary antibody, which is a mouse-absorbed,
biotin-conjugated rabbit anti-rat IgG. Macrophage staining was examined using light
microscopy. Sections incubated with secondary antibody only showed no positive
staining. Three samples in each mouse strain were stained and evaluated.

Elastic modulus measurement. Quasi-static nanoindentation tests were performed on
mouse aortas using a commercial TriboScope nanoindenter with a light microscope
mounted (Hysitron, Minneapolis, MN). A nonporous conospherical fluid cell probe (TI0077) with a radius of curvature of R = 100 µm was chosen. A custom-built sample
holder was used to hold sample and ensure its hydration during indentation test. The
optical images obtained from the microscope will guide the movementt of the indenter
and allow accurate control on the indentation positions.
A trapezoidal load-hold-unload profile, which was composed of a linear loading
portion of 2 seconds, a dwell portion of 20 seconds at a predetermined peak load and a
linear unloading portion of 2 seconds, was used for each indentation. All samples were
tested at peak load of 5 µN during the dwell period. In total, 16 indentations in a 4✕4 grid
were conducted on each sample. The time interval between two indentations was 120
seconds. The distance between two indentation points was 200µm. After indentations,
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the force-displacement data were collected. The elastic moduli of the specimens were
obtained by fitting the force-displacement data to the Oliver-Pharr model.

Elastase activity assay. Elastase activity in the aortic extract (100 µg) from NaCl- and
CaCl2-treated C57Bl/6 and 129/SvEv mice were measured using an elastase assay kit
(AnaSpec, Fremont, CA) with and without 10 mM EDTA according to manufacturer
instructions. Neutrophil elastase gene expression in the aortic tissue of NaCl- and CaCl2treated C57Bl/6 and 129/SvEv mice were examined by RT-PCR as described
previously.24

Statistical analysis. Measurements of aortic diameter, elastin levels, and elastic moduli
were expressed as mean value ± S.D. ANOVA was used to compare aortic diameters.
Student’s t test was used to compare protein expression, MMP activity, and elastic
moduli in different groups. Statistical significance was accepted at the P < .05 levels.
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Results
Aneurysm size and histology. To test the hypothesis that genetic influences contribute
to susceptibility of aneurysm formation, 129/SvEv and C57Bl/6 mice were subjected to
CaCl2-aneurysm induction. Six weeks after periaortic application of CaCl2, 129/SvEv
mice showed a larger increase in abdominal aortic diameter compared to C57Bl/6 mice
(Fig. 1a, b-e and Table 1). The initial aortic diameter between two strains was not
significantly different. At baseline, VVG staining of aortic sections from C57Bl/6 and
129/SvEv mice showed no difference (Fig. 1f, g, j, k) while both showed disruption and
fragmentation of medial elastic lamellae after aneurysm induction (Fig. 1h, i, l, m).
However, aortic elastic lamellae degradation appeared to be more severe in 129/SvEv
mice (Fig. 1i & m) compared to C57Bl/6 mice (Fig. 1h & l). These observations are
consistent with the larger aneurysms that develop in the 129/SvEv mice.

Aortic elastic moduli. The elastic lamella, which is comprised of elastic fibers,
collagens, proteoglycans, and glycosaminoglycans, determines the biomechanical
properties of the aorta. To test the hypothesis that baseline aortic mechanical properties
of C57Bl/6 mice differed from 129/SvEv mice, quasi-static nanoindentation tests were
performed on the aortas isolated from the two strains of mice. The elastic moduli of the
specimens were obtained by fitting the force-displacement data to the Oliver-Pharr
model. The elastic moduli of C57Bl/6 mice were significantly less than that of the
129/SvEv mice (Fig. 2). Thus, the aortic wall in 129/SvEv mice was stiffer or less
compliant than in the C57Bl/6 mice.

Aortic tropoelastin content. Matrix synthesis is known to accompany the matrix
degradation seen in AAA. Production of tropoelastin, the precursor molecule that
becomes incorporated into mature elastin fibers, in the aneurysmal aortas was examined
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Figure 1. Aortic changes after NaCl and CaCl2 treatment in C57Bl/6 and 129/SvEv
mice. Aortic diameters were measured before NaCl or CaCl2 incubation and at sacrifice.
Aortic diameter increases are shown in the bar graph (a). Bars represent the mean +/SD of at least 6 mice per group.

The diameter in the CaCl2-treated groups was

increased significantly at sacrifice in both C57Bl/6 and 129/SvEv mice compared to NaCl
treated mice (* P < .01).

The aortic dilatation in CaCl2-treated 129/SvEv mice was

significantly greater compared to CaCl2-treated C57Bl/6 mice (# P < .05). Photographs
(b-e) show the mouse aortas in C57Bl/6 and 129/SvEv mice with the dotted line
indicating the outer border of the aortas before (b, c) and after (d, e) CaCl2 aneurysm
induction, respectively, (n = 6-10/group). VVG staining for elastic fibers (f-m). Aortic
lamellae disruption (10✕ magnification) (h, i) and elastic fiber fragmentation (40✕
magnification) (l, m) were more severe in 129/SvEv (i. m) than in C57Bl/6 (h, l) mice (n =
3-5/group). n, percentage of aortic circumference showing elastin disruption in CaCl2treated C57Bl/6 and 129/SvEv mice (n = 3 aortas/group).
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Figure 1. Aortic changes after NaCl and CaCl2 treatment in C57Bl/6 and 129/SvEv
mice Aortic diameters were measured before NaCl or CaCl2 incubation and at sacrifice.
Aortic diameter increases are shown in the bar graph (a). Bars represent the mean +/SD of at least 6 mice per group. The diameter in the CaCl2-treated groups was increased
significantly at sacrifice in both C57Bl/6 and 129/SvEv mice compared to NaCl treated
mice (* P < .01). The aortic dilatation in CaCl2-treated 129/SvEv mice was significantly
greater compared to CaCl2-treated C57Bl/6 mice (# P < .05). Photographs (b-e) show the
mouse aortas in C57Bl/6 and 129/SvEv mice with the dotted line indicating the outer
border of the aortas before (b, c) and after (d, e) CaCl2 aneurysm induction, respectively,
(n = 6-10/group). VVG staining for elastic fibers (f-m). Aortic lamellae disruption (10✕
magnification) (h, i) and elastic fiber fragmentation (40✕ magnification) (l, m) were
more severe in 129/SvEv (i. m) than in C57Bl/6 (h, l) mice (n = 3-5/group). n,
percentage of aortic circumference showing elastin disruption in CaCl2-treated C57Bl/6
and 129/SvEv mice (n = 3 aortas/group).
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Table 1.
Table1. Changes in aortic diameter in C57Bl/6 and 129/SvEv mice after
treatment of NaCl and CaCl2
C57Bl/6
Treatment
Number
Pre-treatment (µm)
Post-treatment (µm)
AAA development
(%)
Percent
Increase (%)

NaCl
8
520 ± 14
562 ± 17
0
8.3

CaCl2
16
507 ± 7
797 ± 30 *
56
57.8

129/SvEv
NaCl
6
544 ± 15
628 ± 18
0
15.9

CaCl2
12
550 ± 17
1067 ± 67 *#
83
96.3

Aortic diameters were measured before NaCl or CaCl2 incubation (Pre) and at sacrifice
(Post). Measurements of aortic diameter were expressed as mean ± SE. The percent of
increase was represented as a percent compared with pre-treatment. The development
of aneurysm was defined as at least a 50% increase relative to original aortic diameter. *
P <.01, Student’s t test, compared to pre-treatment; # P < .05 compared to CaCl2-treated
C57Bl/6.
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Figure 2. Elastic modulus of aortic tissues from C57Bl/6 and 129/SvEv mice. Prior
to aneurysm induction, quasi-static nanoindentation tests were performed on the aortas
and the elastic modulus was determined (n = 3 per group, * P < .05).
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Figure 2
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Figure 2. Elastic modulus of aortic tissues from C57Bl/6 and 129/SvE
aneurysm induction, quasi-static nanoindentation tests were performed o
the elastic modulus was determined (n = 3 per group, * P < .05).
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by Western blot analysis. At baseline, there was no different in tropoelastin production
between two strains (Fig. 3a). The tropoelastin levels in CaCl2-treated aortas of
129/SvEv mice were decreased by one third compared to CaCl2-treated aortas of
C57Bl/6 mice (Fig. 3b). The procollagen 1α levels in the aortas were also examined by
Western blot analysis. There was no difference in procollagen 1α content between the
two strains of mice (data not shown). These data suggest that the 129/SvEv mice may
be less able to repair elastin once it has been disrupted.

Aortic MMP-2 and MMP-9 expression.

MMP-2 and MMP-9 are essential for the

connective tissue degradation in the aortic wall leading to AAA. 25 Because the greater
level of elastin degradation in the 129/SvEv mice suggests higher levels of MMP activity,
we determined if the aortas from C57Bl/6 and 129/SvEv mice expressed different levels
of MMP-2 and MMP-9 at baseline and after aneurysm induction. Aortic protein was
analyzed by gelatin zymography. As shown in Figure 4a, latent MMP-2 expression in
untreated 129/SvEv mice was significantly higher than in untreated C57Bl/6 mice.
Furthermore, after aneurysm induction, active forms of MMP-2 and MMP-9 were higher
in the aortas of 129/SvEv mice (Fig. 4b). These results demonstrated that 129/SvEv
mice express higher levels of pro-MMP-2 intrinsically. Additionally, after aortic injury,
there is greater activation of MMP-2 and MMP-9 in 129/SvEv mice.
Increased MMP-9 expression in aortic tissues after aneurysm induction may
indicate higher levels of MMP-9 expression from macrophages or increased
macrophage infiltration into the aortic tissue in 129/SvEv mice compared to C57Bl/6 in
response to CaCl2 treatment. Therefore, aortic tissues were examined for the presence
of Mac3-positive macrophages. The images obtained suggested greater macrophage
infiltration in the 129/SvEv mice aortas compared to C57Bl/6 mice (Fig. 4c). These
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Figure 3. Aortic tropoelastin content. Western blot analysis was used to determine
tropoelastin content from C57Bl/6 and 129/SvEv mice before (a) and after (b) AAA
induction. Relative levels of tropoelastin content in mouse aortas were quantified as
shown in bar graphs (* P < .05 compared to CaCl2-treated C57Bl/6 mice) (n = 57/group).

	
  

40

Figure 3

a. Untreated control
C5Bl/6

129/SvEv

b. CaCl2-treated
C5Bl/6

129/SvEv

Tropoelastin
β-actin

*"

Untreated

CaCl2-treated

Figure 3. Aortic tropoelastin content Western blot analysis was used to determine
tropoelastin content from C57Bl/6 and 129/SvEv mice before (a) and after (b) AAA
induction. Relative levels of tropoelastin content in mouse aortas were quantified as shown
in bar graphs (* P < .05 compared to CaCl2-treated C57Bl/6 mice) (n = 5-7/group).
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Figure 4. Aortic MMP-2 and MMP-9 expression. Gelatin zymography analysis of MMP
activities expressed in the aortas of C57Bl/6 and 129/SvEv mice, a) Untreated controls;
b) CaCl2-treated mice.

Representative zymogram gels are shown in left panels.

Relative levels of pro-MMP-9, MMP-9, pro-MMP-2, MMP-2 in mouse aortas were
quantified and data shown in the bar graphs (* P < .05). c) Representative
immunoperoxidase staining for macrophages of aneurysmal aortic tissues from C57Bl/6
and 129/SvEv mice. Mac3-positive cells are indicated by arrows. Macrophages in aortic
tissue were evaluated and scored with values from 0-3 as previously described (7). Zero
indicates that there were no Mac3-positive cells, 3 indicated many Mac3-positive cells in
a limited area, and 1 and 2 were used to classify intermediate grades of Mac3 positive
cells (n = 3/group).
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Figure 4. Aortic MMP-2 and MMP-9 expression Gelatin zymography analysis of MMP
activities expressed in the aortas of C57Bl/6 and 129/SvEv mice, a) Untreated controls; b)
CaCl2-treated mice. Representative zymogram gels are shown in left panels. Relative levels of
pro-MMP-9, MMP-9, pro-MMP-2, MMP-2 in mouse aortas were quantified and data shown in
the bar graphs (* P < .05). c) Representative immunoperoxidase staining for macrophages of
aneurysmal aortic tissues from C57Bl/6 and 129/SvEv mice. Mac3-positive cells are indicated
by arrows. Macrophages in aortic tissue were evaluated and scored with values from 0-3 as
previously described (7). Zero indicates that there were no Mac3-positive cells, 3 indicated
many Mac3-positive cells in a limited area, and 1 and 2 were used to classify intermediate grades
of Mac3 positive cells (n = 3/group).
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Table 2
Table 2. The concentration of macrophages in the CaCl2-treated aorta of 129/SvEv and
C57Bl/6 mice
Mouse Strain

Macrophages

129/SvEv

2.3 ± 0.6*

C57Bl/6

1.0 ± 0.5

Macrophages in aorta were evaluated and scored with values from 0 to 3. Zero means
no Mac3+ cells and 3 meanys many cells in a limited area, the values of 1 and 2 are
used to classify intermediate grades of infiltration. The values reflect the mean ± SD. * P
= 0.0390, Student’s t-test. n = 3.
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results suggest intrinsic differences in mesenchymal cell MMP-2 levels and also
differences in response to injury.
Aortic elastase activity.

In addition to MMP-2 and -9, other elastases could be

responsible for the elastin degradation in AAA. We measured elastase activity in the
aortic tissue from C57Bl/6 and 129/SvEv mice. Elastolytic activity was similar between
NaCl-treated C57Bl/6 and 129/SvEv mice (Fig. 5a). However, elastase activity in CaCl2treated 129/SvEv and C57Bl/6 mice was significantly higher than NaCl-treated 129/SvEv
or C57Bl/6, respectively (Fig. 5a). Furthermore, compared to CaCl2-treated C57Bl/6
mice, elastolytic activity in CaCl2-treated 129/SvEv was higher (Fig. 5a). Neutrophils
play an important role in aneurysm formation. 114,136 We also tested neutrophil elastase
gene expression using RT-PCR. We found that there were no significant differences
between C57Bl/6 and 129/SvEv mice at baseline or in aneurysmal aortic tissue (Fig. 5b
&c). In order to determine the contribution of MMPs, EDTA was used to block MMP
activity prior to measuring total elastolytic activity (Fig. 5a). These data demonstrated
that the majority of enhanced activity was due to increased elastin degradation by
MMPs.

Role of myelogenous cells in AAA susceptibility. The known role of inflammatory
cells in AAA and differences in the levels of active MMP-9 in the C57Bl/6 and the
129/SvEv mice suggested that there could be intrinsic differences in the myelogenous
cells. In order to investigate this, C57Bl/6-derived bone marrow cells were infused into
irradiated 129/SvEv (SvEvbkg/C57bm) mice and 129/SvEv-derived bone marrow cells
were infused into irradiated C57Bl/6 (C57bkg/SvEvbm) mice. As controls, we also
transplanted bone marrow from C57Bl/6 or 129/SvEv mice into the irradiated, same back
ground mice, C57Bl/6 (C57bkg/C57bm) or 129/SvEv ( SvEvbkg/SvEvbm), respectively. The

	
  

45

Figure 5. Aortic elastase activity and neutrophil elastase expression a) Elastase
activity in aortic tissue extract from C57Bl/6 and 129/SvEv mice was measured, (* P <
.05 compared to NaCl-treated control, # P < .05 compared to CaCl2-treated C57Bl/6
mice) (n = 3/group). EDTA was used to block MMP activity. b) The neutrophil elastase
expression in the aortas of C57Bl/6 and 129/SvEv mice was examined by RT-PCR;
untreated controls (left panel) and CaCl2-treated mice (right panel). c) The levels of
neutrophil elastase mRNA relative to GAPDH in the aorta were quantified; data shown in
the bar graphs (n = 3/group).
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Figure 5. Aortic elastase activity and neutrophil elastase expression a) Elastase
activity in aortic tissue extract from C57Bl/6 and 129/SvEv mice was measured, (* P
< .05 compared to NaCl-treated control, # P < .05 compared to CaCl2-treated C57Bl/6
mice) (n = 3/group). EDTA was used to block MMP activity. b) The neutrophil elastase
expression in the aortas of C57Bl/6 and 129/SvEv mice was examined by RT-PCR;
untreated controls (left panel) and CaCl2-treated mice (right panel). c) The levels of

	
  

47

chimeric mice were subjected to CaCl2-aneurysm induction. Six weeks after aneurysm
induction, SvEvbkg/C57bm developed larger aneurysms than the C57bkg/SvEvbm (Fig. 6a).
Aortic diameter in the SvEvbkg/C57bm increased by 85% ± 4, while the C57bkg/SvEvbm
increased by 56% ± 6 (Table 3). The aortic diameter changes in C57bkg/C57bm and
SvEvbkg/SvEvbm were similar to C57bkg/SvEvbm and SvEvbkg/C57bm, respectively.
Furthermore, the disruption of the elastic lamellae of the aortic wall of CaCl2-treated
C57bkg/SvEvbm was less severe than the SvEvbkg/C57bm chimeric mice (Fig. 6b). Aortic
MMP-2 and MMP-9 levels in C57bkg/SvEvbm mice were lower than in SvEvbkg/C57bm mice
while it is similar between C57bkg/C57bm and C57bkg/SvEvbm and between SvEvbkg/SvEvbm
and SvEvbkg/C57bm(Fig. 6c). The changes in aortic diameter in the chimeric mice were
very similar in magnitude to the differences noted when the background strains were
compared. These data do not support the concept that differences in the white cell
compartments account for differences in aneurysm susceptibility.
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Figure 6. The role of myelogenous cells in AAA susceptibility. The chimeric mice,
C57bkg/C57bm, SvEvbkg/SvEvbm, C57bkg/SvEvbm and SvEvbkg/C57bm, were subjected to
CaCl2 aneurysm induction. Aortic diameter changes were shown in the bar graph (a) (*
P < 0.01 compared to NaCl control; # P < 0.05 C57bkg/SvEvbm vs. SvEvbkg/C57bm and
C57bkg/C57bm vs. SvEvbkg/SvEvbm after CaCl2 treatment). Bars represent the mean ± SD
of 6 mice per group. Representative VVG staining of elastic fibers after aneurysm
induction (b). Gelatin zymography of aortic MMP-2 and -9 levels in CaCl2-treated
C57bkg/C57bm (lane 1), C57bkg/SvEvbm (lane 2), SvEvbkg/SvEvbm (lane 3), and
SvEvbkg/C57bm (lane 4) (c).
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Figure 6. The role of myelogenous cells in AAA susceptibility The chimeric
mice, C57bkg/C57bm, SvEvbkg/SvEvbm, C57bkg/SvEvbm and SvEvbkg/C57bm, were
subjected to CaCl2 aneurysm induction. Aortic diameter changes were shown
in the bar graph (a) (* P < 0.01 compared to NaCl control; # P < 0.05 C57bkg/
SvEvbm vs. SvEvbkg/C57bm and C57bkg/C57bm vs. SvEvbkg/SvEvbm after CaCl2
treatment). Bars represent the mean ± SD of 6 mice per group. Representative
VVG staining of elastic fibers after aneurysm induction (b). Gelatin
zymography of aortic MMP-2 and -9 levels in CaCl2-treated C57bkg/C57bm
(lane 1), C57bkg/SvEvbm (lane 2), SvEvbkg/SvEvbm (lane 3), and SvEvbkg/C57bm

	
  

50

Table 3 Changes in aortic diameter in chimeric mice after treatment of NaCl and CaCl2
C57

bkg

/SvEv

bm

SvEv

bkg

/C57

bm

C57

bkg

/C57

bm

SvEv

bkg

/SvEv

Treatment

NaCl

CaCl2

NaCl

CaCl2

CaCl2

CaCl2

Number

5

5

5

5

4

5

Pre-Treatment
(µm)

505 ± 11

534 ± 12

509 ± 7

510 ± 28

502 ± 20

517 ± 23

PostTreatment
(µm)

540 ± 21

837 ± 48*

531 ± 6

945 ± 71*,#

779 ± 48

960 ±77 Ɨ

AAA
development
(%)

0

60

0

100

50

100

Percent
increase (%)

7

57

4

85

55

86

Aortic diameters were measured before NaCl (or CaCl2) incubation (Pre) and at sacrifice
(Post). Measurements of aortic diameter were expressed as mean ± SD. The percent
of increase was represented as a percent compared with pre-treatment.

The

development of aneurysm was defined as at least 50% increase relative to original
diameter of aortic diameter. * p < .01, student's t test, compared to pre-treatment;

#

p

<.05 compared to CaCl2-treated C57bkg/SvEvbm; Ɨ p < .05 compared to CaCl2-treated
C57bkg/C57bm.

bm
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Discussion
The majority of genomic studies used to identify susceptibility pathways involved
in disease pathologies have been performed in the mouse. 137-139 The mouse provides a
suitable model for the study of human genetics because more than 95% of the genome
is identical. The mouse genome is easy to manipulate allowing diseases to be modeled
in transgenic animals once the target genes have been determined. Mice are also easy
to breed with a short generation time and a short lifespan allowing direct study of
disease development. Abundant evidence, however, demonstrates the profound
influence of genetic background on the course and severity of many diseases.	
   140-‐142
Strain variability has been shown to influence aneurysm formation, progression, and
even lifespan in MFS mouse models. Lima et al. demonstrated the effect of genetic
background on the severity of the MFS phenotype by backcrossing the mg∆ allele, in
which fibrillin-1 expression is reduced to 10% of normal levels, in 129/SvEv and C57Bl/6
mouse strains.

132

The 129/SvEv background was more susceptible to aneurysm

formation and earlier aortic rupture. Increased susceptibility to aneurysm formation in the
129/SvEv background when compared to the C57Bl/6 background was also present in
the least severe model of MFS (Fbn1C1039G/+; 50% normal fibrillin-1 expression levels).
Clearly, the genetic differences between the two strains are relevant to thoracic aortic
aneurysm pathogenesis. To determine whether the development of AAA is dependent
on mouse genetic background, we induced aneurysms in two widely used mouse
strains, C57Bl/6 and 129/SvEv. Mice from both genetic backgrounds displayed
increased aortic diameters and developed aneurysms in response to CaCl2 induction,
but the aneurysms formed in 129/SvEv mice were significantly larger compared to
C57Bl/6 mice. Compared to our previous study, 25 the difference in CaCl2-treated aortic
diameter between two strains was bigger in the present study. In previous study, the
aneurysms in the two strains were not induced concurrently. In the present study, the
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aneurysms in two strains were induced simultaneously with one operator. We believe
this better represents the differences between the two strains. In NaCl-treated controls of
129/SvEv mice, the average increase in aortic diameter was larger than previous
reported. 25 In the present study, we have used a camera having higher resolution to
define the aortic borders. We believe this primarily reflects growth of the aorta between 7
to 14 weeks. Consistent with these differences in aneurysm size, aortic elastic lamellar
disruption and degradation in 129/SvEv mice were more severe compared to C57Bl/6
mice. Age and gender are also important factors in aneurysm development in patients
with AAA. Mice of the same age and gender were used to exclude these as possible
confounding factors.
Our current results, based on determination of the elastic modulus, demonstrate
that the abdominal aortas of 129/SvEv mice were stiffer at baseline than those of
C57Bl/6 mice. There is indirect evidence that patients with AAAs may have a systemic
increase in arterial stiffness. Dijk et al. have shown that the carotid artery is stiffer in AAA
patients compared to control patients without AAA.

143

In order to determine if the

differences in mechanical properties were related to intrinsic differences in gene
expression, we examined aortic elastin and collagen precursor levels prior to aneurysm
induction. C57Bl/6 and 129/SvEv mice express similar levels of tropoelastin and
procollagen (data not shown). There is evidence that the elasticity of arterial wall may
impact susceptibility to arterial diseases. Studies have shown that aortic elastin
haploinsufficiency leads to high blood pressure and progressive aortic valve
malformation. 144,145 We did not measure tail cuff blood pressure in the current study but
other studies have demonstrated that 129/SvEv mice have higher basal blood pressure
than C57Bl/6 mice and 129/SvEv mice are more likely to develop hypertension and renal
damage than C57Bl/6 mice in response to deoxycorticosterone acetate.

146,147

These

results could occur because of baseline differences in mechanical properties or be the
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result of differences in response to exogenous stimuli. Currently, the association
between hypertension and AAA remains unclear. It has been reported that in
angiotensin II (Ang II) infused apoE null mice, AAA formation is independent of blood
pressure elevation.

148-150

We have previously demonstrated that there is an ongoing

repair mechanism in patients with AAA as evidenced by high levels of collagen gene
expression.

151

Six weeks after CaCl2-induction, tropoelastin levels in 129/SvEv mice

were significantly lower than C57Bl/6 mice. Procollagen levels did not differ between the
two strains after aneurysm induction (data not shown). Aneurysm susceptibility may be
related to baseline differences in tissue properties. This difference would be exacerbated
in the 129/SvEv because of the reduced ability to produce equivalent amounts of
tropoelastin as is produced by C57Bl/6.
Matrix metalloproteinases, especially MMP-2 and -9, play important roles in
aneurysm formation. Interestingly, 129/SvEv mice intrinsically produce higher amounts
of latent MMP-2 in the aorta compared to C57Bl/6 mice. This results in higher levels of
active MMP-2 in 129/SvEv after CaCl2-treatment compared to C57Bl/6. MMP-2 is
primarily a product of resident aortic smooth muscle cells and fibroblasts. Initial
degradation of elastin by MMP-2 may produce elastin fragments, which are known to
induce monocyte chemotaxis.

92,152

This may account for the increased macrophage

infiltrates seen in the aortas of 129/SvEv mice compared to C57Bl/6 mice. Baseline
levels of active and latent MMP-9 were similar between the two mouse strains. This is
not unexpected since macrophages are the main source of MMP-9 in aneurysm tissue
but are not present in normal aortic tissue. 153 Levels of both latent and active MMP-9
were higher in 129/SvEv aortas than in C57Bl/6 aortas in response to CaCl2-treatment.
In addition to MMP-2 and -9, other proteases such as MMP-12, MMP-7, MT1-MMP,
neutrophil elastase, and cysteine proteases may contribute to elastin degradation and
aneurysm formation. 114,135,154-156 We tested neutrophil elastase expression in the mouse
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aorta and found no difference between the two mouse strains (Fig. 5b). Using EDTA to
block MMP activity, it is evident that the majority of the increased elastolytic activity is
due to MMPs. These data suggest three possible mechanisms for the increased
aneurysm susceptibility in 129/SvEv. First, the larger reservoir of latent MMP-2 could
result in more elastin fragmentation with resultant recruitment of inflammatory cells to the
aorta. Second, the differences in aneurysm sizes could be related to inherent differences
in tissue mechanical properties. Finally, the myelogenous cells of the 129/SvEv may
produce a more vigorous response to injury, greater elastin degradation, and aortic
expansion.
It is known that inflammatory infiltrates play a pivotal role in aneurysm formation.
21,24,34,157

We investigated whether the myelogenous cell differences between the two

strains of mice contribute to aneurysm susceptibility. Two chimeric mice were created,
C57bkg/SvEvbm mice, hematopoietic tissue ablated C57Bl/6 mice transplanted with
129/SvEv mouse myelogenous cells, and SvEvbkg/C57bm mice, hematopoietic tissue
ablated 129/SvEv mice transplanted with C57Bl/6 mouse bone marrow cells. Six weeks
after CaCl2-aneurysm induction, both chimeric mice produced aneurysms. However, the
aneurysm sizes and pathological changes were similar to mice of their genetic
background. These results demonstrate that myelogenous cells are not responsible for
the background specific differences in aneurysm size between the two mouse strains.
Thus, the difference in aneurysm susceptibility is related to tissue properties, MMP
expression, or some combination of both.
A genetic predisposition to AAA formation is well-documented. 158,159 However,
the genetic basis for this predisposition is unknown. Although animal models may not
perfectly recapitulate human diseases, they can provide mechanistic insight toward
understanding

human

pathology.

The

CaCl2-induced

murine

aneurysm

model

reproduces many features that have been clinically described in human AAA tissue,

	
  

55

including macrophage and T cell recruitment, MMP up-regulation, and elastin
fragmentation. Studies have demonstrated that manipulation of MMP-2 and MMP-9
levels have profound impacts on experimental aneurysm formation.

25,26

The current

studies extend the previous work in demonstrating that even small differences in
baseline or stimulated expression of MMP-2 and MMP-9 affect aneurysm size. Future
studies examining factors regulating MMP gene expression will not only provide a
greater understanding of the pathophysiology, but also may provide potential targets for
therapeutic intervention.
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CHAPTER 3

Elastin-derived peptides enhance M1 macrophage polarization
The following is a modified version of an article published in Journal of Immunology 2016
This work was coauthored by Wanfen Xiong, Jeffrey S. Carson, Melissa K. Suh, Trevor
M. Meisinger, George P. Casale, B. Timothy Baxter, and myself.
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Introduction
A key feature associated with aneurysm formation is loss of ECM and the
destruction of the aortic wall. ECM degradation leads to proteolysis of elastin, the
predominant ECM protein in the aortic wall.

160

Elastin proteolysis releases elastin-

derived peptides (EDPs), including peptides with the xGxxPG motif, a commonly
repeated sequence in elastin. 161 Of those EDPs released by elastin degradation, the
VGVAPG repeat sequence in the human tropoelastin molecule has been shown to have
the highest affinity for elastin-binding protein. 161-164 EDPs are upregulated in the serum
of patients with AAA, and an increase in their level is predictive of AAA expansion.
36,165,166

Previous reports have demonstrated that EDPs recruit inflammatory cells to sites

of ECM damage and neutralizing their effect with BA4, a monoclonal antibody that binds
to VGVAPG and other xGxxPG motifs, prevents elastin damage. 92,93,167,168 The precise
mechanism through which EDPs affect macrophages and subsequently lead to
enhanced tissue damage has not been fully elucidated.
Macrophages play critical roles in the innate immune system, responding to
various stimuli in their microenvironment. They can exist in a pro-inflammatory M1
phenotype as well as an anti-inflammatory M2 phenotype.

169

M1 macrophages are

characteristically described by their release of pro-inflammatory cytokines, such as TNFα and IL-1β. TNF-α, has been shown to be required for experimental aneurysm
formation in mice.

170

Previous studies have demonstrated an increase in M1

macrophages in human AAA tissue. 36,37 In contrast, M2 macrophages are considered
anti-inflammatory, aiding in the healing process by release of IL-10 and profibrotic
factors such as TGF-β.

171

Their role in AAA formation and progression is less well

known. The chronic inflammatory process in AAA promotes aneurysm expansion by
active ECM degradation and pro-inflammatory cell recruitment to areas of tissue
damage, potentially caused by an abnormally high ratio of M1/M2 macrophages. Thus,
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altering the M1/M2 ratio may play an important role in slowing or preventing AAA
expansion.
The purpose of this study was to evaluate the role of the M1/M2 ratio in AAA and
the effect of EDPs on macrophage polarization. These studies were performed by three
different methods. First, EDPs were used to examine whether they polarize
macrophages to a pro-inflammatory M1 or anti-inflammatory M2 phenotype in vitro.
Next, M1 or M2 macrophages were injected into mice in order to directly alter the M1/M2
ratio in the CaCl2 AAA model. Finally, the effect of direct inhibition of EDPs on AAA and
macrophage polarization was examined by administration of BA4 after aneurysm
induction.
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Methods
Reagents
Monoclonal anti-elastin antibody BA4, IgG, soluble elastin, and LPS were
purchased from Sigma-Aldrich (St. Louis, MO, USA). VGVAPG peptide was purchased
from Elastin Products Company (Owensville, MO, USA). Mouse IFN-γ and IL-4 were
purchased from R&D systems (Minneapolis, MN, USA).

Mouse aneurysm induction model
The Institutional Animal Care and Use Committee (IACUC) approved all animal
procedures. Male C57BL/6 mice at 8 weeks of age were obtained from The Jackson
Laboratory (Bar Harbor, ME, USA). Mice underwent surgery as described previously. 172
To induce AAA, mice were anesthetized with tribromethanol (250 mg/kg; Sigma Aldrich)
and underwent laparotomy. The abdominal aorta between the iliac artery bifurcation and
renal arteries was isolated from the surrounding retroperitoneal structures. Next, the
external diameter of the abdominal aorta was measured in triplicate midway between the
renal arteries and iliac artery bifurcation. After baseline measurements, periaortic
application of 0.25 M CaCl2 was administered for 15 minutes followed by two washes
with 0.9% sterile saline. Sterile saline (0.9% NaCl) replaced 0.25 M CaCl2 in sham
control mice. The laparotomy incision was closed followed immediately by subcutaneous
injections of buprenorphine (0.15 mg/ml) for analgesic after surgery.

Anti-EDP antibody injections
After aortic exposure, application of CaCl2, and closure of the laparotomy
incision, antibody treatment was administered by intraperitoneal injection of BA4 (10
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mg/kg) or IgG (10 mg/kg) in CaCl2-treated mice. NaCl-treated mice received no
treatment after laparotomy. Weekly injections of BA4 or IgG continued for six weeks
after initial injection. One week or six weeks after surgery, mice underwent laparotomy
and isolation of the infrarenal aorta. Tissue from BA4-treated mice were harvested one
week after aneurysm induction in order to allow one injection of the antibody to have its
potential full effect based on previous work showing that 10 mg/kg of BA4 is still
detectable in the serum one week after i.p. injection. 94 Measurements were repeated in
triplicate at the same locations as baseline measurements. Mice were sacrificed and the
entire infrarenal aorta was removed for protein or mRNA isolation or histological studies.
For histological studies, aortic tissue was perfusion-fixed with 10% neutral buffered
formalin.

Bone marrow-derived macrophage isolation
Bone marrow-derived macrophages (BMDMs) were isolated from C57Bl/6 or
C57Bl/6J-Tg(UBC-GFP)30Scha/J (GFP) mice as described previously. 173 Briefly, mice
were euthanized by cervical dislocation. The femur and tibia were isolated from the
surrounding muscle tissue and sterilized in 70% ethanol for 15 seconds then washed in
PBS (1x). The ends of each femur and tibia were removed and the bone marrow was
flushed out with Dulbecco’s modified eagle medium (DMEM) supplemented with 1% fetal
bovine serum (FBS) using a 25-gauge needle. Bone marrow cells were then passed
through a cell strainer, washed with 1x PBS after centrifugation, then plated in a T75
dish at 1x107 cells per 10 ml of BMDM media. BMDM media is defined as DMEM
supplemented with 10% FBS, 20% conditioned medium from L929 cells (a source of MCSF), 1% Penicillin/Streptomycin, and 1% glutamine. BMDMs were grown at 37oC for
seven days and media was removed and replaced with fresh BMDM media every two
days. Flow cytometric analysis was used to determine purity of F4/80 positive
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macrophages (98.6%). After seven days of growth, cells were treated for 24 hours with
one of the five following treatments: No Tx (no treatment), M1 [IFN-γ (20 ng/ml) and LPS
(100 ng/ml)], M2 [IL-4 (20 ng/ml)], EDP (1 µg/ml), or VGVAPG (1 µg/ml). Cell media was
collected and RNA was isolated from the cells using TriZol according to manufacturer’s
instructions. RNA levels were examined using qPCR analysis with SYBR Green
(BioRad). GAPDH was used as an internal control.

Bone marrow-derived macrophage polarization and injection
Bone marrow cells were isolated and differentiated into macrophages as
described above. After differentiation, BMDMs were treated with IFN-γ and LPS (M1) or
IL-4 (M2). After polarization, 5x106 M1 or M2 BMDMs were injected into the mouse
circulation via the tail vein. Mice were subjected to CaCl2-induced aneurysm induction 24
hours after M1 or M2 injection. As a control, a group of mice received no M1 or M2
macrophages prior to CaCl2 treatment. Mice were monitored for three days or six weeks.
The three day-time point was chosen based on data presented in Supplemenatry Figure
1, where expression of M1 and M2 associated markers are highest in the aortic tissue
after application of CaCl2. Mice were sacrificed and the infrarenal aortic tissue was
collected for histological, flow cytometry, RNA, or protein analysis.

Histology and microscopy
After perfusion-fixation with 10% neutral buffered formalin, aortic tissue samples
were embedded in paraffin and sectioned into 4 µm sections. For Verhoeff-Van Gieson
(VVG) staining, sections were stained with Verhoeff’s solution, ferric chloride, sodium
thiosulfate, and Van Gieson’s solution. After each staining cycle, a fixing and washing
procedure followed. Slides were then examined and photographed using light
microscopy (40×; Nikon). Four sections were viewed per mouse.
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Supplementary Figure 1. Aortic tissue mRNA levels of Ym1, CD206, and iNOS after
aneurysm induction with CaCl2. Levels were examined at day zero, three days (D3),
one week (D7), two weeks (D14), four weeks (D28), and six weeks (D42) after aneurysm
induction (n = 3-4 aortas per group). GAPDH used as internal control. Data expressed
as mean ± SEM.
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Supplementary Figure 1
Figure 1

Supplementary Figure 1. Aortic tissue mRNA levels of Ym1, CD206, and
iNOS after aneurysm induction with CaCl2. Levels were examined at day
zero, three days (D3), one week (D7), two weeks (D14), four weeks (D28),
and six weeks (D42) after aneurysm induction (n = 3-4 aortas per group).
GAPDH used as internal control. Data expressed as mean ± SEM.

	
  

64

Flow Cytometry
Aortic tissue from mice was isolated and digested for one hour at 37oC with
collagenase and elastase in RPMI with 1% FBS.

174

In order to isolate cells, the

suspension from the digested tissue was filtered through a 40 µm filter. Cells were then
pelleted by centrifugation and resuspended in flow cytometry staining buffer (1× PBS
with 1% FBS). Cells were blocked with anti-mouse CD16/32 (1 µg/ml; BD Biosciences,
San Diego, CA, USA) before surface labeling with the following antibodies: AlexaFluor
700-labeled CD86 (BioLegend, San Diego, CA, USA) APC-labeled F4/80 (BioLegend)
and RPE-labeled CD206 (Bio-Rad Laboratories, Hercules, CA, USA). Flow cytometry
data were analyzed using BD FACSDIVA software.

Detection of TNF-α concentration
Bone marrow-derived macrophages were isolated as described above. Media
was collected from cells after incubation with increasing doses of EDP (0.01, 0.1, 1.0,
10, 100 µg/ml), VGVAPG (1 µg/ml), IFN-γ (20 ng/ml) and LPS (100 ng/ml), or IL-4 (20
ng/ml) for 24 hours. Cell media was used in a TNF-α ELISA from R&D Systems
(Minneapolis, MN, USA) according to manufacturer’s instructions.

Immunofluorescence
Mice that were injected with M1 or M2 macrophages were sacrificed at three
days after aneurysm induction for macrophage staining performed on paraffin-embedded
4 µm aortic sections. After deparaffinizing the sections, antigen retrieval was performed
using Proteinase K (Viagen Biotech, Los Angeles, CA, USA; 20 µg/ml in TE buffer pH
8.0). Sections were incubated in the Proteinase K working solution for three minutes at
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room temperature. Sections were then washed and blocked with 10% normal goat
serum. Rat monoclonal anti-F4/80 (ab6640, Abcam, Cambridge, MA, USA) diluted 1:400
was applied to the sections and incubated at room temperature for one hour. Sections
were then washed and incubated with AlexaFlour 488 goat anti-rat IgG (A-11006, Life
Technologies, Grand Island, NY, USA) diluted 1:200 for one hour at room temperature.
Slides were then mounted with ProLong gold antifade mountant with DAPI (P-36931,
Life Technologies). Fluorescence images were captured with a Leica epifluorescence
widefield microscope (DMRXA2) and CCD camera (Orca C4742; Hamamatsu
Photonics, Bridgewater, NJ, USA), with Hamamatsu software (HCImage 4.0).

Immunohistochemistry
Mice underwent AAA induction according to the method described above. Three
to four mice from the NaCl, CaCl2-IgG, CaCl2-BA4 were sacrificed six weeks after
aneurysm induction. Paraffin-embedded aortic sections were stained for CD206 (M2)
and CD86 (M1). Sections were incubated with monoclonal rabbit anti-mouse CD86
(Abcam) diluted 1/500 or monoclonal rabbit anti-mannose receptor (CD206; Abcam)
diluted 1/100 for 30 minutes at 37oC. The sections were then briefly washed in citrate
solution followed by incubation with a biotin-conjugated rat anti-rabbit IgG. CD206 and
CD86 stained sections were examined by light microscopy (40×). The number of CD206
or CD86 positive cells per high powered field were counted and displayed in a bar graph.
Four separate sections from each aorta were stained and evaluated.

Gelatin zymography
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Aortic tissue protein was extracted as previously described and protein
concentration was measured using the Bio-Rad protein assay (Bio-Rad Laboratories,
Hercules, CA, USA). 175 Gelatin zymography was performed as previously described. 172
Standardized protein samples (5 µg) were resolved by nondenaturing electrophoresis
with 0.8% gelatin in a 10% SDS-polyacrylamide gel. Molecular sizes of gelatinolytic
activity were determined using protein standards (Bio-Rad). Signal intensities were
quantified using ImageJ version 1.38x software (NIH, Bethesda, MD, USA).

Statistical analysis
The change in external aortic diameter over the course of aneurysm
development was compared to baseline for each animal, and results for each group
were expressed as mean ± SEM. ANOVA and post-hoc t-test with Bonferroni’s
correction were used to compare multiple groups. Statistical significance was accepted
at a P-value < .05.
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Results
Elastin-derived peptides promoted a pro-inflammatory M1 phenotype
To determine the role that EDPs have on macrophage phenotype, bone marrow
cells were isolated and differentiated into BMDMs. To establish control M1 or M2 cells,
BMDMs were treated with IFN-γ and LPS (M1), IL-4 (M2), or left untreated (No Tx) for 24
hours (Fig. 1A). To examine the effect of elastin fragments on macrophage polarization,
BMDMs were treated with 1 µg/ml of EDPs or VGVAPG for 24 hours. EDP and
VGVAPG treatment induced mRNA expression of M1 associated markers, such as TNFα and IL-1β (Fig. 1A). In contrast, mRNA expression of M2 markers, CD206 and Ym1,
was not affected by EDP or VGVAPG treatment (Fig. 1A). MMP-9 mRNA expression
was also increased by EDP or VGVAPG treatment (Fig. 1A). To determine if the EDPmediated M1 polarization was concentration dependent, BMDMs were treated with
increasing doses of EDPs. An ELISA demonstrated a stepwise increase in TNF-α levels
in the media with increasing doses of EDPs (Fig. 1B).

M2 macrophages reduced aortic dilation in an experimental AAA model
To determine the in vivo effects of influencing the M1/M2 ratio in an experimental
AAA model, macrophages polarized to the M1 or M2 phenotype were injected
intravenously into mice 24 hours prior to aneurysm induction. Cells were sampled from
each treatment group prior to injection and M1 or M2 polarization was confirmed by
protein expression of M1 (iNOS) and M2 (Ym1) markers (Fig. 2B). A control group of
mice underwent aneurysm induction without injection of macrophages (Control). Aortic
diameters were measured six weeks after aneurysm induction. Three of the eight mice
that received M1 macrophages were sacrificed prior to the six-week time point due to
severe systemic illness; necropsy revealed severe aortic damage in these mice. All of
the mice that received M2 macrophages (9/9) survived to the six-week time point.
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Figure 1. Elastin-derived peptides polarize macrophages to a pro-inflammatory M1
phenotype. A) qPCR analysis of M1 and M2 phenotype markers after treatment of
macrophages with IFN-γ and LPS (M1), IL-4 (M2), VGVAPG (1 µg/ml), or EDP (1 µg/ml)
for 24 hours. GAPDH was used as an internal control. B) ELISA measurement of TNF-α
levels from EDP- or VGVAPG-treated macrophage media. Statistics performed using
ANOVA and Student’s t-tests. Data expressed as mean ± SEM. *, P < .05; **, P < .01
versus no treatment (No Tx).
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Figure 2. M1 and M2 macrophage influence on aortic size six weeks after
aneurysm induction. A) Schematic representation of method of BMDM isolation,
injection, and aortic aneurysm induction. B) Representative image of protein expression
of M1 (iNOS) or M2 (Ym1) markers of macrophages treated with IFN-γ (20 ng/ml) and
LPS (100 ng/ml) or IL-4 (20 ng/ml) prior to injection. C) Aortic diameter percent increase
six weeks after aneurysm induction with M1 or M2 macrophage injection (n = 5-9 per
group). Statistics performed using ANOVA and Student’s t-tests. Data expressed as
mean ± SEM. *, P < .05; **, P < .01. D) Representative VVG images of aortas six weeks
after aneurysm induction with injection of M1, M2, or no macrophages (Control) (n = 3-4
per group). VVG image of aorta from a mouse that required sacrifice within one week
after aneurysm induction. Arrows indicate sites of elastin fragmentation.
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Figure 2. M1 and M2 macrophage influence on aortic size six weeks after
aneurysm induction. A) Schematic representation of method of BMDM
isolation, injection, and aortic aneurysm induction. B) Representative image
of protein expression of M1 (iNOS) or M2 (Ym1) markers of macrophages
treated with IFN-γ (20 ng/ml) and LPS (100 ng/ml) or IL-4 (20 ng/ml) prior to
injection. C) Aortic diameter percent increase six weeks after aneurysm
induction with M1 or M2 macrophage injection (n = 5-9 per group). Statistics
performed using ANOVA and Student’s t-tests. Data expressed as mean ±
SEM. *, P < .05; **, P < .01. D) Representative VVG images of aortas six
weeks after aneurysm induction with injection of
M1, M2, or no
macrophages (Control) (n = 3-4 per group). VVG image of aorta from a
mouse that required sacrifice within one week after aneurysm induction.
Arrows indicate sites of elastin fragmentation.
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Comparing survival (5/8 vs. 9/9) between the two groups by Fisher’s exact test
demonstrated a P-value of 0.08. While M1 macrophage injection did not show a
statistically significant increase in aortic diameter, the trend toward larger aneurysms
may have been attenuated by the three mice that required sacrifice prior to six weeks.
The aortic diameters from mice injected with M2 macrophages were significantly smaller
than CaCl2-treated control mice or mice injected with M1 macrophages (Fig. 2C).
Connective tissue staining indicated robust elastin degradation in aortas from the M1
injected mice compared to CaCl2-treated control mice. The most severe elastin
degradation was seen in mice sacrificed prior to the six-week time point (Fig. 2D). Aortas
from M2-injected mice displayed overall elastin preservation six weeks after aneurysm
induction (Fig. 2D). The elastin preservation seen in these animals coincided with a
decrease in levels of both MMP-9 and MMP-2 in M2-injected mice compared to M1injected mice (Fig. 3). No differences in MMP levels were seen between Control and M1injected mice.

Infleunce of M1 and M2 macrophages at three days
To determine the effect of M1 or M2 macrophages on early aortic aneurysm
formation, CaCl2- or NaCl-treated mice that had undergone M1 or M2 injection were
sacrificed three days after aneurysm induction. The effect of the M2 macrophages
observed at six weeks was also seen at the earlier three-day time point (Fig. 4B). In
contrast to the six-week time point, M1 macrophage injection did show a significant
increase in aortic diameter compared to CaCl2-treated control mice. M1 or M2 injection
had no effect on aortic diameter in NaCl-treated mice (Fig. 4B). In order to assess that
the injection of M1 or M2 cells were having a local effect on the macrophage population
in the aortic tissue, cells were isolated from the aorta by enzymatic digestion three days
after aneurysm induction. Cells were analyzed by flow cytometry to determine the ratio
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Figure 3. Active MMP-2 and MMP-9 levels are decreased in mice injected with M2
macrophages. Signal intensities of ProMMP-9 MMP-9, ProMMP-2, and MMP-2 were
quantified using ImageJ software. Statistics performed using ANOVA and Student’s ttests. Data are presented as mean ± SEM (n = 4-5 aortas per group). *, P < .05.
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Figure 4. M1 and M2 macrophage influence on aortic size three days after
aneurysm induction. A) Schematic representation of methods three days after
aneurysm induction and macrophage injection. B) Aortic diameter percent increase three
days after aneurysm induction with injection of M1, M2, or no macrophages (Control) (n
= 5-6 per group). NaCl was used as sham control. C) Bar graph on left represents
M1/M2 ratio of M1 (CD86) to M2 (CD206) positive macrophages (F4/80) from flow
cytometry (n = 5-6 per group). Right bar graph shows proportion of F4/80+ macrophages
found in tissue. D) Representative immunofluorescence and VVG stained images of
aortas three days after surgery and M1 or M2 macrophage injection (n = 3 per group).
Top panel shows aortas stained with a rat anti-mouse F4/80 antibody (red), cell nuclei
stained with DAPI (blue); bottom panel shows VVG stained aortas. Arrows indicate sites
of elastin fragmentation or abnormal structure. Statistics performed using ANOVA and
Student’s t-tests. Data expressed as mean ± SEM. *, P < .05; **, P < .01.
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Figure 4. M1 and M2 macrophage influence on aortic size three days after
aneurysm induction. A) Schematic representation of methods three days after
aneurysm induction and macrophage injection. B) Aortic diameter percent
increase three days after aneurysm induction with injection of M1, M2, or no
macrophages (Control) (n = 5-6 per group). NaCl was used as sham control. C)
Bar graph on left represents M1/M2 ratio of M1 (CD86) to M2 (CD206) positive
macrophages (F4/80) from flow cytometry (n = 5-6 per group). Right bar graph
shows proportion of F4/80+ macrophages found in tissue. D) Representative
immunofluorescence and VVG stained images of aortas three days after surgery
and M1 or M2 macrophage injection (n = 3 per group). Top panel shows aortas
stained with a rat anti-mouse F4/80 antibody (red), cell nuclei stained with DAPI
(blue); bottom panel shows VVG stained aortas. Arrows indicate sites of elastin
fragmentation or abnormal structure. Statistics performed using ANOVA and
Student’s t-tests. Data expressed as mean ± SEM. *, P < .05; **, P < .01.
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of M1 to M2 polarized cells (Fig 4C). These data demonstrated a higher M1/M2 ratio in
the aortas of M1-injected mice and a decreased ratio in M2-injected mice. By
immunofluorescence staining, there did not appear to be a difference in the total number
macrophages in aortic tissue when comparing M1- to M2-injected mice (Fig. 4D). This
was consistent with flow cytometry data showing no difference in the percentage of
F4/80+ macrophages in the aortic tissue. Connective tissue staining revealed that M1
macrophage injection resulted in severe elastin fragmentation three days after aneurysm
induction; the corresponding immunofluorescence studies indicated a high concentration
of macrophages adjacent to the sites of marked elastin damage (Fig. 4D). Aortas from
M2-injected mice showed preserved elastin architecture.
In order to determine whether injected macrophages migrated to the aorta, GFP+
BMDMs were incubated with IFN-γ and LPS (M1) and IL-4 (M2). After polarization, GFP+
M1 or GFP+ M2 cells were injected intravenously into mice 24 hours prior to aneurysm
induction. Aortic tissue was harvested three days after aneurysm induction, digested,
and a single cell suspension was analyzed by flow cytometry. GFP+ cells were found in
aortas of 6/7 mice injected with M1 cells and 5/6 mice injected with M2 cells. Further
analysis revealed that 1.18% ± 0.22 of the total M1 cells detected in the M1-injected
mice were GFP+ and that 9.25% ± 2.74 of the total M2 cells detected in the M2-injected
mice were GFP+.

BA4 reduced aortic diameter and elastin degradation
BA4 is a monoclonal antibody that specifically binds xGxxPG motifs, particularly
VGVAPG, which is a common motif repeated in elastin. Previous studies have shown
that BA4 reduces monocyte/macrophage chemotaxis in diseases associated with elastin
fragmentation, such as Marfan syndrome and emphysema. 92,94 To determine if BA4 can
reduce aortic dilation in AAA, mice were treated with weekly i.p. injections of BA4 (10
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Figure 5. BA4 attenuates aortic dilation and elastin degradation. A) Schematic
representation of methods for weekly anti-EDP treatment. B) Percent increase in aortic
diameter six weeks after aneurysm induction and treatment with IgG or BA4 (n = 7-8
mice per group). C) Representative gelatin zymogram of mouse aortic tissue six weeks
after aneurysm induction. Signal intensities of MMP-2, ProMMP-2, and MMP-9 were
quantified using ImageJ software. Statistics performed using ANOVA and Student’s ttests. Data are presented as mean ± SEM (n = 4-5 aortas per group). *, P < .05; **, P <
.01. C) Representative VVG staining of aortic tissue sections from NaCl, CaCl2 IgG, and
CaCl2 BA4 treated mice (n = 3-4 aortas per group). Arrows indicate sites of elastin
damage.
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Figure 5. BA4 attenuates aortic dilation and elastin degradation. A)
Schematic representation of methods for weekly anti-EDP treatment. B)
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gelatin zymogram of mouse aortic tissue six weeks after aneurysm induction.
Signal intensities of MMP-2, ProMMP-2, and MMP-9 were quantified using
ImageJ software. Statistics performed using ANOVA and Student’s t-tests.
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80

mg/kg) after CaCl2 aneurysm induction. A control group of mice received weekly
injections of non-specific IgG (10 mg/kg). Six weeks after aneurysm induction, mice were
sacrificed and aortas harvested for analysis. BA4 reduced aortic dilation compared to
IgG treatment (Fig. 5B). Active forms of both MMP-9 and MMP-2 in aortic tissue were
also decreased in BA4-treated mice, whereas the inactive form of MMP-2 was not
significantly reduced (Fig. 5C). Connective tissue staining revealed general elastin
preservation in aortas from BA4-treated mice (Fig. 5D). Treatment with NaCl had no
effect on elastin fragmentation. Immunohistochemical staining revealed an increase in
CD206 positive cells (M2 macrophage marker) in aortic tissue from BA4-treated mice
compared to NaCl and IgG-treated mice (Supplementary Fig. 2). The number of CD86
positive cells was higher in aortas from IgG-treated mice but not significantly different
from NaCl or BA4-treated mice.
In order to better understand the early pathogenesis of aneurysm formation, the
effects of EDP neutralization were evaluated one week after aneurysm induction. Aortic
diameter was increased in both BA4-treated and IgG-treated mice; however, IgG-treated
mice exhibited a markedly greater increase in diameter (Fig. 6A). A previous study
showed that monocyte/macrophage chemotaxis in response to human AAA explants
was reduced by preincubation of the tissue with BA4. 167 In this present study, BA4’s
ability to reduce macrophage migration in vivo was assessed by flow cytometry. As
expected, migration of F4/80+ macrophages to aortic tissue was increased after CaCl2IgG treatment compared to NaCl treatment (Fig. 6B). BA4 reduced the frequency of
macrophage migration to the baseline levels seen in NaCl-treated aortas. Gelatin
zymography demonstrated that BA4 treatment reduced the active forms of both MMP-2
and MMP-9 in aortic tissue at one week (Fig. 6C). M1 or M2 polarization was assessed
in aortic tissue after CaCl2 treatment. Quantitative PCR revealed downregulation of M1
associated genes (TNF-α, CD86) and upregulation of M2 associated genes (CD206,
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Supplementary Figure 2. BA4 increases CD206+ macrophages in aortic tissue.
Representative immunohistochemisty of CD206 or CD86 positive cells in aortic tissue six
weeks after aneurysm induction. Bar graph represents number of CD206 or CD86
positive cells per high powered field (HPF). The anti-CD86 antibody demonstrated some
nonspecific binding to connective tissue. Arrows indicate representative CD206 or CD86
positive cells. Statistics performed using ANOVA and Student’s t-tests. Data are
presented as mean ± SEM (n = 4-5 aortas per group). *, P < .05; **, P < .01.
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Supplementary Figure 2. BA4 increases CD206+ macrophages in aortic
tissue. Representative immunohistochemisty of CD206 or CD86 positive
cells in aortic tissue six weeks after aneurysm induction. Bar graph
represents number of CD206 or CD86 positive cells per high powered field
(HPF). The anti-CD86 antibody demonstrated some nonspecific binding to
connective tissue. Arrows indicate representative CD206 or CD86 positive
cells. Statistics performed using ANOVA and Student’s t-tests. Data are
presented as mean ± SEM (n = 4-5 aortas per group). *, P < .05; **, P < .01.
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Figure 6. BA4 reduced macrophage migration, MMP production, and the ratio of
M1/M2 markers in aortic tissue one week after aneurysm induction. A) Percent
increase aortic diameter one week after aneurysm induction (n = 8-10 per group). B)
Number of F4/80 positive cells in NaCl, CaCl2-IgG, and CaCl2-BA4 treated aortas (n = 78 per group). C) Representative gelatin zymogram of aortic tissue one week after
aneurysm induction. Bar graphs represent signal intensities of ProMMP-9, MMP-9,
ProMMP-2, and MMP-2 by quantification with ImageJ software (n = 3-4 per group). Data
expressed as mean ± SEM. *, P < .05; **, P < .01. D) Fold change in mRNA expression
of M1 and M2 associated markers from aortic tissue of mice treated with CaCl2-IgG or
CaCl2-BA4 compared to NaCl-treated mice one week after aneurysm induction (n = 4
per group). GAPDH was used as internal control. Dashed line indicates NaCl control
(fold change = 1). Statistics performed using ANOVA and Student’s t-tests. Data
expressed as mean ± SEM. *, P < .05; **, P < .01 versus NaCl. †, P < .05; ††, P < .01
versus CaCl2-IgG treatment.
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Figure 6. BA4 reduced macrophage migration, MMP production, and the
ratio of M1/M2 markers in aortic tissue one week after aneurysm induction.
A) Percent increase aortic diameter one week after aneurysm induction (n =
8-10 per group). B) Number of F4/80 positive cells in NaCl, CaCl2-IgG, and
CaCl2-BA4 treated aortas (n = 7-8 per group). C) Representative gelatin
zymogram of aortic tissue one week after aneurysm induction. Bar graphs
represent signal intensities of ProMMP-9, MMP-9, ProMMP-2, and MMP-2
by quantification with ImageJ software (n = 3-4 per group). Data expressed
as mean ± SEM. *, P < .05; **, P < .01. D) Fold change in mRNA expression
of M1 and M2 associated markers from aortic tissue of mice treated with
CaCl2-IgG or CaCl2-BA4 compared to NaCl-treated mice one week after
aneurysm induction (n = 4 per group). GAPDH was used as internal control.
Dashed line indicates NaCl control (fold change = 1). Statistics performed
using ANOVA and Student’s t-tests. Data expressed as mean ± SEM. *, P
< .05; **, P < .01 versus NaCl. †, P < .05; ††, P < .01 versus CaCl2-IgG
treatment.
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Ym1) with BA4 treatment (Fig. 6D). Many typical pro-inflammatory markers identified in
aneurysm tissue were decreased by BA4 treatment (Supplementary Fig. 3A) while antiinflammatory markers were increased (Supplementary Fig. 3B). By Western blot
analysis, the M2-associated marker Ym1 was increased in BA4-treated aortic tissue
compared to IgG treatment (Supplementary Fig. 4).
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Supplementary Figure 3. BA4 treatment promotes an anti-inflammatory
environment in aortic tissue one week after aneurysm induction. A) Bar graphs
represent fold change in mRNA expression levels of pro-inflammatory and M1
associated markers from aortic tissue relative to NaCl controls (dashed line) one week
after surgery. B) Bar graphs represent fold change in mRNA expression levels of antiinflammatory and M2 associated markers from aortic tissue relative to NaCl controls
(dashed line) one week after aneurysm induction (n = 4 per group). GAPDH was used as
internal control. Statistics perfumed using ANOVA and Student’s t-tests. Data expressed
as mean ± SEM. *, P < .05; **, P < .01 versus NaCl. †, P < .05; ††, P < .01 versus
CaCl2-IgG treatment.
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Supplemental Figure 3

	
  
Supplementary Figure 4. Aortic tissue protein levels of Ym1 one week after BA4
treatment. Bar graph represents relative protein expression levels of Ym1 one week
after aneurysm induction and IgG or BA4 treatment (n = 4 aortas per group). GAPDH
used as internal control. Statistics perfumed using ANOVA and Student’s t-tests. Data
expressed as mean ± SEM. *, P < .05.
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Discussion
Using a murine model of AAA, we found that M1 macrophages strongly promoted
aneurysm formation. This effect was seen as early as three days after aneurysm
induction; aortic diameters were larger in the M1-infused group. This increase was not
significant compared to CaCl2-treated control at six weeks. This may be explained,
however, by the fact that three of the eight mice treated with M1 macrophages required
sacrifice within one week of aneurysm induction due to severe systemic illness. Postmortem examination of the aortic tissue from these three mice demonstrated severe
elastin damage not typically seen until six weeks. This early morbidity is atypical for this
model and was not seen in any of the M2-treated mice, suggesting that an excess
number of M1 macrophages may be toxic. Conversely, M2 macrophage infusion was
highly protective against elastin degradation and aneurysm formation. Furthermore,
EDPs, systemic levels of which are elevated in AAA patients, 176 promoted polarization of
macrophages to a pro-inflammatory M1 phenotype. EDPs also enhanced the
transcription of MMP-9, which has previously been shown to be required for AAA
development. 172,177 In vitro studies showed that EDPs or the VGVAPG peptide did not
upregulate expression of M2-associated genes. Administration of the antibody BA4,
which binds the repeated elastin motif VGVAPG, dramatically reduced aortic dilation,
elastin fragmentation, and MMP production. BA4 lowered M1 and raised M2 markers
early after aneurysm induction, leading to a reduction in aneurysm formation at six
weeks.
EDPs are created as a result of breakdown of elastin, a key extracellular matrix
protein that is present in the skin, lungs, arteries, and other structures. Elastin makes up
50% of the aortic wall proteins by weight. 178 Once elastin is incorporated into the tissue
structure, there is little to no turnover except under pathological conditions.

92,179-181

Previous studies have shown that EDPs are increased in the serum of patients with
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AAAs. 165,166,176 EDPs have been shown to have inflammatory properties by examination
of their effects on lymphocytes and MMP expression; they increase Th1 associated
cytokines and MMP-9 synthesis.

182

This polarization of lymphocytes appears to be

mediated through a receptor for specific EDPs, since it can be blocked by neutralization
of the elastin receptor or with lactose, which causes shedding of the receptor from the
cell membrane. 161 Similar treatment inhibited monocyte migration when monocytes were
exposed to human AAA tissue extract. 167 A previous study has suggested that EDPs
may have an anti-inflammatory effect on macrophages under specific conditions. 183 In
contrast, the present study indicated that EDPs had a profound pro-inflammatory effect.
Furthermore, we demonstrated that this effect was mediated by promoting M1
macrophage polarization.
Chronic inflammation occurs in the aortic tissue of patients with AAA; the
predominate cell types found in this infiltrate are T lymphocytes and macrophages. 30,184
Inflammation induced by ablumenal application of CaCl2 in a model of AAA recapitulates
many features seen in human AAA tissue including macrophage and lymphocyte
infiltration, MMP upregulation, elastin degradation, and aortic dilation.

31,155,172,185

Pro-

inflammatory M1-associated cytokines such as TNF-α, IL-6, and IFN-γ are increased in
both human and experimental AAAs.

36,37

Deletion or neutralization of these M1-

associated cytokines resulted in reduced aortic dilation or complete aneurysm inhibition.
100,101,170,175

M1 or M2 macrophage polarization can have a significant role in regulating

chronic inflammatory processes; little is known about the role of M1 or M2 macrophage
polarization in aortic aneurysms. We demonstrated that the pro-inflammatory state
induced by CaCl2 was enhanced by supplementation with M1-polarized macrophages.
M2 macrophage injection rescued the aorta from expansion and elastin disruption. The
pathogenesis of aneurysm development was altered early in its course by M2
macrophages, where the impact on aortic dilation and elastin fragmentation could be
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seen as early as three days after aneurysm induction. Taken together, these data
demonstrate that the M1/M2 ratio plays a fundamental role in aneurysm development,
and could prove an important therapeutic target.
By using flow cytometry, we were able to determine that injected macrophages
are able to migrate to the damaged aorta. This small proportion of injected cells found in
the aorta three days after aneurysm induction may not completely account for how these
cells induce the distinct aortic phenotypes observed. It is known that small populations of
cells, such as T regulatory cells, can have a major effect on inflammatory processes in
both human and murine AAAs. 76,186 These injected M1 or M2 cells may also be acting
systemically by increasing circulating levels of cytokines levels vital to aneurysm
formation. Injection of M1 macrophages led to early mortality in three mice within a week
of aneurysm induction suggesting a profound systemic inflammatory response not seen
in M2-injected mice. These injected M1 or M2 cells may also be influencing other cell
types important in aneurysm formation such as T regulatory cells.

187

In the case of

injected M2 cells, they may be creating a positive feedback loop by enhancing other antiinflammatory cell populations. These populations may further enhance the M2
phenotype leading to decreased damage to the aortic wall and preservation of elastin.
Previous studies have shown that macrophages are not terminally differentiated and
have the ability to change phenotypes over time. 188-190 Future studies will focus on better
understanding these mechanisms and, particularly, the potential benefit of injecting
macrophages polarized to the M2 phenotype.
The elastin-binding protein is assumed to have a role in normal elastin assembly
by secreting the elastin precursor, tropoelastin, into the ECM. 191 This protein is found on
many cell types, including cells that don’t normally produce elastin.

192

This study

suggests that the elastin-binding protein, through its interaction with EDPs, contributes to
disease pathogenesis when present on inflammatory cells such as macrophages.
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Previous studies have shown that the peptide sequence predominantly recognized by
the elastin-binding protein is VGVAPG. Other peptides of this motif, xGxxPG, have a
lower affinity for the elastin-binding protein. 193 These particular motifs are found primarily
in elastin, but are also present to a lesser extent in other connective tissue proteins.
Binding of the BA4 antibody to elastin fragments with the xGxxPG motif reduces or
inhibits cellular activation in response to the presence of EDPs.

92-94,167, 194

In this study,

we demonstrate this critical role of EDPs in potentiating aneurysm formation, in part,
through the elastin-binding protein on macrophages. The in vitro studies indicated that
the mechanism for this effect is mediated by altering macrophage polarization. As
expected, BA4 reduced macrophage migration to the site of aortic injury. Importantly, the
BA4 treatment also influenced production of M1 and M2 related proteins, reducing the
pro-inflammatory microenvironment caused by EDPs. Since M2 macrophages are
known to play a role in healing, the effects seen with BA4 may represent attempted
tissue repair.
In conclusion, this study demonstrated that EDPs have an important role in
promoting aneurysm expansion by altering the macrophage phenotype. This increase in
M1/M2 ratio would be expected to create a positive feedback loop by further degradation
of the elastin matrix and continued release of EDPs. The profound inhibitory effects of
the M2 macrophages suggest a key role in preventing small aneurysm expansion. All
current treatments for aortic aneurysms rely on mechanical intervention. Yet, when most
AAAs are detected, they are below the threshold for repair leading to a significant
observation period during which there is currently no medical therapy to prevent or slow
aneurysm growth. The results presented herein suggest that decreasing the M1/M2
ratio, either by neutralization of pro-inflammatory EDPs or enhancing the antiinflammatory environment created by M2 macrophages, could prove a useful therapeutic
target for small aortic aneurysms.
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DISSERTATION DISCUSSION
The course of human AAA is a long, complex, and multifactorial process. Most
patients are asymptomatic until the AAA ruptures, which 90% of the time results in
death. 195 Of those patients that have been diagnosed and are aware of their aneurysm,
a period of cautious waiting occurs until the aneurysm is dilated enough to need surgical
intervention. While advances in surgical techniques have reduced the immediate
complications after open aneurysm repair, 196 the game of waiting for this ticking time
bomb to rupture needs to become obsolete. Therefore, the need for pharmacological
intervention is critical in order to prevent the progression or stimulate the regression of
established AAAs. Clinical trials are underway in order to identify a therapeutic
alternative to mechanical AAA intervention.
Studies on human AAA tissue focus on the end stage of disease since the tissue
is obtained most often at the time of open aneurysm repair when the aorta is significantly
enlarged and damaged. In addition, the ability to obtain human AAA tissue is decreasing
as endovascular AAA repair increases. Therefore, in order to study AAA pathogenesis,
animal models must be used. The three most commonly used murine AAA models are
the ApoE-/- angiotensin-II infusion model, elastase perfusion, and CaCl2 topical
application. The CaCl2 model is able to recapitulate many characteristics similar to
human AAA such as elastin degradation, inflammatory cell infiltration, and MMP
upregulation. This model and the elastase perfusion model are less widely used due to
their technical challenges compared to the ApoE-/- angiotensin-II infusion model.
Regardless of the AAA model used, these murine models are considered to be acute
models that cannot completely capture the chronic inflammatory disease process
occurring in human AAAs.
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By using the CaCl2 aneurysm model on two different strains of mice, C57Bl/6 and
129/SvEv, the dissimilarities seen in aortic growth, MMP production, and inflammatory
cell infiltration can mimic the heterogeneity seen between patients with AAAs. These
important findings show that baseline and activated MMP differences seen between the
129/SvEv and C57Bl/6 mice have a vital role in the aortic growth rate. These data can
help to explain why one patient’s aneurysm may grow at a faster rate than another’s.
Aortic diameter can provide important information as to how susceptible the patient may
be to aortic rupture. Being able to produce larger aneurysms in the 129/SvEv mouse
could help to recreate the characteristics observed in tissue taken from large human
AAAs obtained at the time of surgery. These larger aneurysms could also recapitulate
the pathological processes occurring in human patients at the time of aneurysm rupture
since a large aneurysm diameter is predictive of the susceptibility to rupture.
Specific genetic linkages are known for thoracic aortic aneurysms, such the
fibrillin-1 mutation in MFS or the TGF-β receptor 1 mutation in Loeys-Dietz syndrome.
Heredity influences AAA susceptibility, however, a specific genetic linkage for the
susceptibility to AAA formation has not yet been discovered. Moreover, it is not yet
known why male siblings of known patients have a greater risk of developing AAAs. 197
Recent studies have identified mutations in kallikrein 1, a serine protease, or MMP-3 as
genetic loci associated with AAA formation. 198,199 The increased levels of Pro-MMP-2 at
baseline and six weeks after aneurysm induction in mice indicate that these proteases
are vital to the growth rate of aneurysm formation. The differences seen in aneurysm
size between the 129/SvEv and C57Bl/6 mice may not simply be due to a mutation in
MMP-2, as implied by the kallikrein 1 and MMP-3 mutations identified in human AAA, but
also due to the pathways involved in MMP-2 activation. Since the activated levels of
MMP-2 in 129/SvEv mice were no different from C57Bl/6 mice prior to aneurysm
induction but significantly increased six weeks after application of CaCl2, these data
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imply a difference in the activation pathway associated with MMP-2. Previous studies
demonstrate that membrane-type 1 MMP cleaves Pro-MMP-2 to active MMP-2 and that
membrane- type 1 MMP levels were elevated in human AAA tissue. 200 Mice deficient in
membrane-type 1 MMP were unable to form aneurysms. 135 The results presented herein
indicate that future directions should be focused not just on inactivation of MMPs, but
also on pathways leading to MMP activation.
Knowledge of pathways and proteases associated with ECM degradation is
critical to understand the destruction process associated with AAA formation.
Investigation of the reparative process is equally as important in developing therapeutic
targets. Stopping the aortic wall degradation process is important in preventing
aneurysms from growing large enough to rupture, but this does not fix the damaged
structural integrity of the aortic wall. Focus should also be directed to promoting
pathways associated with aortic repair, where restoration of a healthy aortic diameter is
the objective. The differences in tropoelastin observed between C57Bl/6 mice and
129/SvEv mice demonstrate unequal reparative processes. C57Bl/6 mice express higher
levels of tropoelastin, which may answer why these mice develop smaller aneurysms
and exhibit reduced elastin degradation compared to 129/SvEv mice that underwent the
same treatment. While baseline levels of tropoelastin indicate no difference in protein
expression between C57Bl/6 and 129/SvEv mice, increased levels of tropoelastin are
seen in the C57Bl/6 mice six weeks after aneurysm induction. These data demonstrate
that pathways associated with ECM deposition, specifically elastin deposition, are
increased. Human AAA tissue expresses lower levels of tropoelastin than human tissue
from an atheromatous plaque, indicating that an inability to properly repair the damaged
aorta may be leading to outward remodeling and aneurysm formation. 201
The genetic differences seen between these two strains of mice imply that the
reason why some patients develop AAA while others develop atherosclerotic plaques
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may not only be due to differences in proteolytic process but also due to differences in
reparative processes. Therapeutic targets enhancing proper tissue repair is vital to
correcting the abnormal aortic dilation. This process will undoubtedly be quite difficult
considering the formation of mature elastin is complex. Many proteins, such as fibrillin-1,
fibronectin, and lysyl oxidase are involved in the proper formation of mature elastin while
specific timing associated with their expression is critical.

202

Recreating the complex

temporal, spatial, and structural interactions for proper elastin fiber assembly will be
challenging. If all of the proteins are not deposited in the proper quantities and proper
order, the repaired aorta will likely be prone to aneurysm formation as evidenced in MFS
where fibrillin-1 deficiency results in ascending aortic aneurysm formation. Producing
enough elastin to combat the proteolytic process produced by MMPs is essential, but
producing too much elastin may create complications as evidenced by the release of
EDPs.
Elastin is the major ECM protein responsible for maintaining an artery’s elastic
properties. These mechanical properties are important for small to medium sized arteries
ability to maintain blood pressure. Elastin in larger arteries, such as the aorta, has a role
in load bearing in relation to tension in the aortic wall. 203 As seen in the data presented
herein, breakdown of elastin in these larger arteries results in release of EDPs, which
promote pro-inflammatory M1 macrophage polarization. Serum from patients with AAAs
has higher levels of EDPs when compared to serum from patients with other vascular
diseases such as atherosclerosis. The initial damage to the aortic wall likely results in
release of EDPs into the blood stream, creating a pro-inflammatory environment and
enhancing the chronic inflammation associated with AAAs. Whether AAA is caused by
genetics, patient lifestyle, or some traumatic event, release of these EDPs most certainly
exacerbates disease progression. Targeting these free floating or exposed elastin
fragments could prove to be a useful therapeutic target in slowing the rate of aneurysmal
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growth or even stimulating aneurysm regression. Stopping these EDPs from creating a
pro-inflammatory environment or directly altering the ratio of pro-inflammatory M1 cells
to anti-inflammatory M2 cells are exciting new prospects in understanding the disease
process. The data presented demonstrates that blocking EDPs could be a therapeutic
target. Not only does neutralization of EDPs with BA4 reduce MMP activity, but it also
limits the recruitment of macrophages to the aortic wall. Of those macrophages that were
able to infiltrate the mouse aortic wall, a higher number of alternatively activated M2 cells
were present in BA4-treated mice than classically activated M1 cells. The proinflammatory environment commonly found in the aortic wall of this animal model had
switched to an anti-inflammatory environment by neutralization of EDPs, potentially
promoting tissue repair. Further investigation into how neutralization of EDPs affects
already established mouse aneurysms is needed. This scenario would better
recapitulate the stage of the disease typically found in patients diagnosed with AAAs.
Determining what effect EDP neutralization has on other cell types in the aortic wall is
also important, since the phenotype of T cells or SMCs have also been found to play a
role in AAA formation and repair.
While AAAs have a complex and multifactorial disease process, studies have
been able to identify common inflammatory cells found in the aneurysmal wall. CD4+ T
cells can exist in many different phenotypes ranging from the pro-inflammatory Th1 or
Th17 cells to the anti-inflammatory Th2 or Treg cells. Serum samples from patients with
AAA have demonstrated a deficiency in the anti-inflammatory Treg population when
compared to age- and sex-matched controls.76 Furthermore, animal studies have
demonstrated that the deletion or expansion of Treg cells can have harmful or beneficial
effects on aneurysm formation, respectively.

204,205

The same could be true for

macrophages. Whether there is a deficiency in anti-inflammatory M2 macrophages
circulating in serum from AAA patients or in AAA tissue compared to disease-matched
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patients has yet to be determined. Conflicting data exists concerning the phenotype of
macrophages found in human AAA tissue. By using the CaCl2 AAA model, we
demonstrated that macrophages are pro-inflammatory after the initial insult, and then
may progress to a more anti-inflammatory phenotype over time. The proportion of
M1/M2 cells is vital at various time points along the course of the disease progression.
By directly altering that M1/M2 phenotype ratio through tail vein injection of M1 or M2
cells, we were able to change the course of the disease. This M1/M2 balance is likely
very delicate. Further studies are needed to elucidate the direct mechanism of how
injection of M2 cells was able to minimize aortic dilation. Furthermore, manipulation of
the M1/M2 phenotypes in established aneurysms needs to be investigated to properly
capture the AAA clinical scenario. Whether the goal should be to enhance the M2
phenotype or decrease the M1 phenotype has yet to be determined. Taken together,
targeting the M1/M2 ratio by either direct injection of M2 macrophages or
pharmacological manipulation of the M1/M2 ratio may provide an important therapeutic
target.
AAA is a genetic, inflammatory, and life-threatening disease. As of yet, only
surgical intervention and smoking cessation have been shown to be effective treatment
strategies. No medical therapy currently exists. Until we are able to understand more
about factors that exacerbate aneurysmal growth or the genetic predisposition of some
patients developing AAA, mechanical intervention is the only solution. One of the
difficulties is obtaining human AAA tissue. This difficulty is increasing due to the less
invasive surgical techniques employed today. Finding tissue that is not toward the end
stage of the disease and close to aneurysmal rupture is rare. Therefore, we must turn to
animal models of disease. Animal models do well at recapitulating many of the features
associated with human AAAs, but in the end they are just models, and each have their
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pitfalls. However, the data obtained from animal models is necessary and can provide
much needed insight into many of the pathways and processes associated with AAAs.
In summary, genetic differences observed between C57Bl/6 and 129/SvEv
indicate that baseline and activated levels of MMP-2 are vital to aneurysm formation and
explain the differences in aneurysm susceptibility between the two models. With the
decreased tropoelastin production and increased elastase activity seen in the 129/SvEv
mice after aneurysm induction, there is high probability that pathways associated with
elastin breakdown and formation are significant in the pathogenesis of AAAs. Elastin
breakdown releases pro-inflammatory EDPs which polarize macrophages to an M1
phenotype. Neutralization of these EDPs in vivo with BA4 minimized aortic dilation by
reducing MMP-2 and MMP-9 activity, reducing macrophage infiltration, and altering the
pro-inflammatory environment created by M1 macrophages. The effect of these M1
macrophages can be altered by directly injecting anti-inflammatory M2 cells, thereby
decreasing the M1/M2 ratio and promoting tissue repair rather than creating chronic
inflammation. These insights can help identify genetic linkages in AAA and lead to
prospective new strategies for medical therapy.
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